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 If no reference genome exists, then the generation of a de novo genome assembly 
of an organism is necessary because having a reference genome expedites the discoveries 
for simple and complex traits. Reference genomes for the domestic dog (Canis lupus 
familiaris) and chicken (Gallus gallus) have resulted in the development of single 
nucleotide polymorphism (SNP) arrays for use in genome-wide association studies 
(GWAS). Next-generation sequencing technologies provide a rapid, increasingly 
affordable method for the generation of genome resequencing data.  
 
 The first objective of this work was to utilize existing genomic resources to 
investigate the genetic basis for traits of the dog and chicken. Episodic falling syndrome 
(EFS) is a recessive neurological disease of Cavalier King Charles spaniels. Using SNP 
profiles from only 12 individuals, EFS was mapped to chromosome 7; further 
experimentation led to the identification of the causative deletion. In a second example, 
SNP profiles from 197 German shepherd dogs were generated to identify loci underlying 
numerous diseases afflicting the breed, including recessive pituitary dwarfism, and three 
complex diseases: degenerative myelopathy, megaesophagus, and pancreatic acinar 
atrophy. Lastly, SNP profiles for 60 Araucana chickens were used to identify an 
association with the semi-dominant tailless rump (rumpless) phenotype on chromosome 
2, as well as the recessive lethal ear-tufts phenotype on chromosome 15. Positional 
candidate genes were identified for both traits.    
 iii 
The second objective of this work was to identify loci associated with 
dermatomyositis (DM) and to develop resources to facilitate the identification of the 
causative mutation. DM is an inflammatory myopathy affecting humans and domestic 
dogs, primarily the collie and Shetland sheepdog breeds where painful lesions on the face 
and extremities are characteristics. The second objective was accomplished through 1) 
assembly of a population of DM-affected and healthy control collies, 2) completion of a 
GWAS using SNP profiles generated for this population, and 3) establishment of whole-
genome resequencing data from 3 DM-affected collies and 2 healthy controls. Results 
revealed a strong association on chromosome 10. Annotation of the collie genome 
yielded novel SNPs, structural variants, and selective sweeps, and regions of reduced 
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OBJECTIVES OF THE DISSERTATION  
My thesis is organized into two broad objectives. In the first I investigated several 
simple to complex traits (Chapters II-IV), and the second objective was to identify loci 
associated with dermatomyositis (DM) and to develop resources to facilitate the 
identification of the causative mutation (Chapters V and VI).  
 
In the first objective I identified the genetic mutation that causes the autosomal 
recessive disease, Episodic falling syndrome, in the Cavalier King Charles spaniel 
(CKCS) breed (1). This was achieved by 1) using a genome-wide association study 
(GWAS) to identify the genetic region associated with the disease, 2) defining a 
haplotype present in affected CKCSs, 3) validate candidate genes to identify the 
causative mutation, a microdeletion in BCAN, present in affected and carrier CKCS, and 
4) developing a genetic test to screen for carriers in the CKCS population (1) (Chapter 
II).  
 
Next, I identified loci associated with four diseases (pituitary dwarfism, 
degenerative myelopathy, congenital megaesophagous (ME), and pancreatic acinar 
atrophy (PAA)) in the German shepherd dog (GSD) (2). The process for all four diseases 
was identical; 1) generating single nucleotide polymorphism (SNP) profiles for 197 dogs 
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and completing a GWAS for each disease and 2) determining haplotypes for each of the 
genetic regions identified. Candidate genes for pituitary dwarfism and degenerative 
myelopathy, LHX3and SOD1, were identified, respectively (2). ME and PAA proved to 
be complex diseases with multiple regions of association and no single causative 
mutation was identified (2) (Chapter III). 
 
In the final part of the first objective, I identified the loci associated with the 
tailless and ear-tuft phenotypes in the Araucana chicken (3). This was achieved by 
conducting two GWASs using the same population of Araucana chickens and 
determining a haplotype for each of the genetic regions identified (3) (Chapter IV).  
 
For the second objective, I studied dermatomyositis (DM), which is an 
autoimmune disease with a variable age of onset predominantly affecting collies (4). 
Although DM is known to be autosomal dominant with incomplete penetrance the 
causative mutation had not been identified (4). Using a GWAS with 27 DM affected and 
20 controls collies, I identified a 10.5 Mb candidate region on chromosome 10 associated 
with DM. However, the coverage of the SNPs in the haplotype region was insufficient to 
discern a narrower region of interest. There are more than 130 identified genes through 
conservation of synteny with human chromosome 12 (5). However, only five 
homologous genes have been identified in the canine reference genome (Broad 
CanFam3.1) within the syntenic region (5) (Chapter V). The SNPs on the Illumina 
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CanineHD Infinium BeadChip are based on the most homogenous dog breeds, which 
currently excludes the collie (6).  
With the long term aim of identifying the causative mutation of DM, I used next-
generation sequencing (NGS) to resequence five collie dogs to map additional SNPs and 
structural variations unique to the collie, which is the final part of my thesis research. 
Five phenotypically diverse American collies (three DM and two control) from the 
original study were resequenced. Each collie was independently mapped to the canine 
reference genome to identify the polymorphisms and regions of reduced heterozygosity 
and structural variants unique to the collie breed. This was achieved by 1) generating 
2x100 paired-end sequencing data; 2) aligning the remaining concordant paired sequence 
reads to the canine reference genome; and 3) identification of SNPS, structural variants 
common to all collies, and regions of reduced heterozygosity that could indicate the 
presence of selective sweeps in the collie breed.  
 
I identified 9.7 million SNPs and more than 670 thousand structural variants 
(insertions, deletions, inversions, tandem repeats, and breakpoints) common to the collie 
genome in this cohort. Comparing the newly identified SNPs with the Illumina 
CanineHD Infinium BeadChip validated these data. Approximately 36,000 of these SNPs 
were predicted missense, splice site, frameshift, stop gained, and stop lost mutations. 
Finally, for validation of the structural variants within the resequenced data. I selected the 
largest structural variants in the following four classes: deletions, insertions, inversions 
and tandem duplications (Chapter VI).  
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THE RELATIONSHIP OF GENETIC VARIATION TO PHENOTYPE  
Canine 
 The dog (Canis lupus familiaris) was the first animal to be domesticated by 
humans (7) and it is one of the most phenotypically diverse mammals (8-10). Through 
selection, humans have created isolated populations of each dog breed (11). In order for a 
dog to be a registered breed, both of its parents must be of the same registered breed. This 
is referred to as the pedigree barrier, which maintains the closure of each population 
(12,13). The existence of multiple dog breeds, a highly homozygous population unto 
themselves, makes the dog a valuable model in understanding the relationships between 
genotypes and phenotypes (7). The regions of homozygosity are up to 1 x 106 bp 
intrabreed and about 1 x 104 bp interbreed (6). SNPs are located throughout the genome. 
Because of the large regions homozygosity within a breed genomic changes exhibit 
significant statistical differences allowing for the identification of a large region(s) of 
association. The smaller regions of homozygosity between breeds are then used to narrow 
the candidate region. Thus, together, the regions within and between breeds are 
advantageous for identifying regions of association through the use of methods such as 
SNP array (BeadChip), GWAS, and fine mapping. (1,2,14,15-18).   
  
 The collie, the German Shepherd dog, and the Cavalier King Charles spaniel (Fig. 
1) are examples of three breeds with genome variations leading to alternate phenotypic 
traits such as snout length and shape, fur length, body size and ear position. The collie 
originated from Scotland and Northern England, where it was selected for its sheep 
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herding abilities (19). The standard collie has either long or short fur, a distinctive long 
nose (dolichocephalic) and upright ears (15,19). The German Shepherd dog was 
originally a herding dog (20), but it is now prized for its aptitude for learning new skills, 
and protective nature (20). They have long fur, mid-length noses (mesocephalic) and tall 
pointed ears (15,20). The Cavalier King Charles spaniel however, is a type of English toy 
spaniel bred for companionship (21,22). These dogs have flat faces (brachycephalic), 
medium length fur, folded ears and a smaller physical size (22). These traits are examples 
of monogenic or polygenic genome variations.   
 
 
Fig. 1. Diverse phenotypes of a collie, German Shepherd dog (GSD), and Cavalier King Charles spaniel 
(CKCS) (from left to right). The collie has a long nose, long or short fur, and upright ears. GSD have mid 
length noses, large pointed ears and long dark fur, whereas CKCS have short noses, floppy ears and are 
physically smaller (15,19-22).  
 




SNP array (BeadChip) and GWAS have been the successfully applied as the 
standard approach to identify the regions of association for the above traits (23-25). 
Where fine mapping was employed the region of association was narrowed and in some 
cases the causative mutation identified. For example, snout length and shape is a 
polygenic trait with candidate regions on chromosomes 1 and 5 (23). The combinatorial 
effect and identity of causative gene(s) has yet to be determined (23). The genetic basis 
for long and short fur length is determined by a single SNP in exon 1 of FGF5, which 
was identified by a GWAS approach and fine mapping of candidate genes (24). Although 
a single IGF1 allele acts as a major determinant of small dog body size (25), a number of 
other loci contribute modifier genes, including GHR, HMGA2, SMAD2, and STC2, which 
influence overall body size, indicating that control of body size is a polygenetic trait (26). 
Ear position, erect versus floppy ears, has been studied using a GWAS, however the 
causative mutation was not determined, rather a 100 kb region of strongest association on 
chromosome 10 near MSRB3 was identified (23).  
  
 In addition, canines have more than 350 known hereditary diseases, many with 
similar clinical signs to humans (16), making the dog a promising model for the study of 
genetic diseases as different breeds are predisposed toward certain diseases (27-29). The 
increased homogeneity within a breed allows for the identification of a candidate 
association region. When several breeds suffer from the same disease, due to the reduced 
homozygosity between breeds, the region of interest can be significantly narrowed with 
the ultimate goal of identifying the causative mutation (7). For example, collies, Shetland 
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sheepdogs, and Labrador retrievers tend to get dermatologic diseases (4). Certain large 
breed dogs such as German shepherd dogs, Labrador retrievers, and Great Danes, have a 
tendency to develop hip dysplasia (30). 
 
 Identification of the genetic causes of disease has also used the standard SNP 
array, GWAS and fine mapping approach. However, the introduction of whole-genome 
resequencing using massive parallel sequencing (a.k.a. NGS) has recently proven to be a 
powerful method in identifying genomic variations that can then be associated with 
known disease phenotypes (31-33). Using the Korean Jindo dog, 339 SNPs in 222 genes 
were identified, of which the study confirmed 89 SNPs in genes previously associated 
with human disease (32). In future studies, SNPs and other genomic variations will be 
used to identify candidate mutations responsible for diseases with no known genetic basis 




 Studies on phenotypic variations in the chicken (Gallus gallus) using the SNP 
array and GWAS approach have been delayed due to the lack of a suitable SNP array and 
comprehensive comparative genomic tools (34). Only a few quantitative traits and 
morphological variants have been classically mapped to a single gene mutation (35). A 
major deterrent to design of a useful SNP array, i.e. at least 100k informative genetic 
markers, was the lack of sufficient suitable genetic markers to accommodate the diverse 
range of chicken breeds (>240) (34). Two proprietary low and medium density SNP 
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arrays (3,000 and 60,000 genetic markers) were recently developed based on 7 breeds 
(36-39). 
 
In this study, I examined the genetic basis for the rumplessness and ear-tuft 
phenotypes in the Araucana chicken (3) using the Illumina 60 k SNP array. The interest 
in these phenotypes rests in the fact that they are two of the three required breed standard 
traits for chicken fanciers in the United States (3,40), the third trait being the pea comb 
(41). Moreover, the lack of the tail vertebrae and associated soft tissue structures and the 
craniofacial anomalies in the ear-tufted birds are potential models for human diseases. 
Using the SNP array and GWAS analysis, I identified the region of association for each 
phenotype. Both traits segregate independently in the population; therefore, we were able 
to use individuals from the same population for each GWAS (3). Rumplessness was 
associated with a 2.14 Mb region on chromosome 2; and the ear-tufts phenotype was 
associated with a 0.58 Mb region on chromosome 15 (3) (Chapter IV). 
 
Since this study, a large collection of SNPs that segregate within >243 chicken 
populations, has been identified (34). In 2013, a high-density 600k SNP array was 
developed in conjunction with Affymetrix and it is the first commercially available SNP 
array for the chicken (34). Our study, among a handful of others, provided the proof of 
principle for the SNP array and GWAS approach in identifying the genetic basis of 




 In this section I briefly discuss the main techniques used throughout this study. 
The first section covers genetic techniques: linkage disequilibrium mapping and genome-
wide association studies. In the second section two genomic techniques used include 
microarray analysis and next-generation sequencing. Finally, I briefly discuss some of the 
limitations of these approaches. 
 
Genetic – linkage disequilibrium mapping 
 Linkage disequilibrium (LD) mapping utilizes the nonrandom association 
between alleles at multiple loci, which may be on more than one chromosome, to find an 
association with the phenotype of interest (44). LD is defined as the frequency of a 
haplotype, i.e. co-inherited loci that do not exhibit the expected random recombination 
(44). This method is used to identify marker-trait associations (45). Unlike, linkage 
mapping, LD is measured in base pairs and is therefore a physical distance between 
defined genetic markers. The more homozygous a species the longer the region of 
homozygosity, up to 1 x 106 bp within dog breeds and about 1 x 104 bp between dog 
breeds (6). This means that a relatively low number of genetic markers are needed for a 
mapping study in dogs (46). Comparative genomics between the dog and humans (Homo 
sapiens) show that humans have considerably less LD compared to the dog (46,47), i.e. 
shorter regions of homozygosity. This means that humans are more heterogeneous than 
the dog, exhibiting increased genetic diversity, and require larger numbers of genetic 
markers for determining regions of association. In a further example, LD mapping and 
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GWAS (discussed below) was used to identify recombination occurring in mitochondrial 
DNA (mtDNA) in hominids (47). The combined LD mapping and GWAS data showed 
reduced LD within mtDNA in both humans and chimpanzees (47).  
 
Genetic – genome-wide association study  
 A genome-wide association study (GWAS) uses a set of genetic markers, 
comparing two groups that vary by one phenotype, to identify an association between 
genetic markers and the phenotype (48). This method is important because it does not 
require previous knowledge of which genes or pathways the phenotype of interest is 
related to (49). Advantages of the association method are 1) that association can detect 
genes that have only a small effect on the phenotype, 2) that genetic markers closer to the 
causative mutation can be identified, and 3) that unrelated individuals can be compared 
(49), none of which is possible with the less informative classical linkage studies. 
 
 GWASs have been applied to humans, model organisms, and non-model 
organisms (48). The predominant genetic marker being used for these associations is the 
single nucleotide polymorphism (SNP) (49). Significant SNPs define a region of 
association identifying a locus. Validation of SNPs is done using direct sequencing to 
confirm that the SNP matches the association with the observed phenotype. Association 
regions indicate the approximate region in the genome where the causative mutation of 
the phenotype is located (50). GWAS in itself is unable to determine the nature of the 
causative mutation. The causative mutation within the region of association needs to be 
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identified by fine mapping.  
 
Genomic – polymorphism detection – microarrays 
 The use of microarrays to detect polymorphisms utilizes tens of thousands to 
millions of oligonucleotide probes to hybridize target DNA to an array (51).  The types of 
probes may be sequence-specific oligonucleotide such as in the Affymetrix GeneChip® 
assay (52). Two probes are designated as a set, and each set member will detect one allele 
of a SNP (Allele A or Allele B) present in a DNA sequence (52). Another method, used 
in Illumina Infinium BeadChip arrays, is to hybridize the fragments of sample DNA with 
oligonucleotides attached to microbeads in order to detect SNPs (53). 
 
 The use of DNA microarray as a means for SNP detection was initially used to 
identify the association of SNPs with cancer (53). SNP arrays generate profiles for 
affected and unaffected populations (54). By conducting statistical comparisons, the 
significant SNP(s) associated with the affected phenotype are identified (54). Since the 
actual locations of the SNPs in the genome are known, candidate chromosomal regions of 
interest can be analyzed to identify the genetic cause of the phenotype (54).  
 
Genomic – polymorphism detection – next-generation sequencing 
 The introduction of massively parallel sequencing (a.k.a next-generation 
sequencing (NGS)) has enabled identification of enormous numbers of SNPs and copy 
number polymorphisms simultaneously (55). When compared to available reference 
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sequences that structural variations within an individual genome can be identified (56). 
Moreover, increasingly sophisticated algorithms have enabled the more accurate 
generation of de novo reference sequences (55). These techniques have the power to alter 
understanding of the mutational spectrum in model organisms and humans (55). 
 
 SNPs exist almost universally and have become the primary genetic marker for 
genetic and genomic analyses (57). Based on the reduced costs, in addition to 
improvements in next-generation sequencing (NGS) and the bioinformatics needed to 
process the data, many projects to identify SNPs in model and non-model organisms have 
been undertaken (57). There are 3 major NGS technologies, and, because of the dynamic 
nature of their maximum capabilities, the method chosen for a specific type of research 
project may vary (57). The 3 NGS technologies are: 454 or Roche sequencing, Illuminia 
sequencing, and Applied Biosystems or SOLiD sequencing (57). In a single day, each 
one of these platforms can generate upwards of 1 Gb of data  (57). 
 
 In order to handle the amount and type of NGS data produced, many analysis 
software packages are available, including, free and commercial, compatible on various 
computer platforms, proprietary and flexible capabilities (57). Regardless of whichever 
NGS platform and analysis software are used, the intended objective is usually to conduct 
SNP discovery (57). SNP detection by NGS has been successful in humans, fruit flies, 
grains, vegetables, and other species (57). 
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 The method by which SNPs are detected in NGS data depends on the presence or 
absence of a reference genome (57). With a reference genome, a NGS read that aligns 
with only a single mismatch to the reference genome will be called a SNP (57). Without a 
reference genome, NGS reads produce a de novo genome assembly, and then aligned 
reads are compared for a single mismatch (57). Both of these methods are theoretical 
since the actual process requires additional information: read depth, quality scores, and 
consensus base ratios (not discussed) (57). 
 
Limitations of approaches  
 The above techniques have both strengths (as discussed above) and limitations. 
Linkage mapping has shortcomings in that crossover events are not random. The 
existence of one crossover can interfere with another one occurring in nearby proximity 
(58,59). Multiple crossover events can cause underestimation of the recombination 
frequency when such events occur between the two points being calculated (44). Another 
issue that affects linkage between two loci is the existence of recombination hotspots in 
eukaryotic chromosomes (60,61). Finally, in related individuals modes of inheritance 
(epistasis, pleiotropy) can adversely affect the accuracy of linkage. As an example, 
incomplete penetrance (where some individuals with the genotype do not display the 
phenotype) can lead to a false negative (62). 
 
 Linkage disequilibrium mapping has weaknesses related to population 
stratification. In population stratification, genetic markers may register a false positive 
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(an association) or false negative (no association) in heterogeneous backgrounds (63,64). 
Furthermore, as linkage disequilibrium measures the degree to which alleles at two loci 
are associated, in related populations linkage disequilibrium analysis requires multiple 
generations and large numbers of related individuals, to identify significant association 
with the phenotype due to the homogeneity within the population (65). 
 
When SNPs are used as the genetic marker, they do not exist in complete 
independence (49). Although GWAS has been successful at identifying simple traits, 
only a limited number of complex traits have been identified due to the complexity of 
heritability (65). It is possible that rare variants, epistasis, epigenetics, and environmental 
factors are being overlooked (65).  
 
 As for SNP arrays, two major limitations are the presence of nonspecific 
hybridization and the extensive period required for hybridization (53). A further 
limitation of microarrays is that there are batch effects that complicate the ability to 
compare data, between experiments (66). 
 
 Although NGS is the most advanced technology, it too, has limitations. Variant 
discovery is reliant on there being sufficient depth of coverage to accurately determine 
variance (67). NGS platforms have biases in amplification from the PCR, resulting in 
bias in amplification of certain transcripts and the introduction of errors within the 
sequence (57).  
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ABBREVIATIONS 
Table 1. Abbreviations used throughout the introduction. 
Name	   Abbreviation	  
Cavalier	  King	  Charles	  spaniel	   CKCS	  
Dermatomyositis	   DM	  
Genome-­‐wide	  Association	  Study	   GWAS	  
German	  Shepherd	  dog	   GSD	  
Linkage	  disequilibrium	   LD	  
Megaesophagus	   ME	  
Mitochondrial	  DNA	   mtDNA	  
Next-­‐generation	  sequencing	   NGS	  
Pancreatic	  acinar	  atrophy	   PAA	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ABSTRACT 
Episodic falling syndrome (EFS) is a canine paroxysmal hypertonicity disorder 
found in Cavalier King Charles spaniels. Episodes are triggered by exercise, stress or 
excitement and characterized by progressive hypertonicity throughout the thoracic and 
pelvic limbs, resulting in a characteristic 'deer-stalking' position and/or collapse. We used 
a genome-wide association strategy to map the EFS locus to a 3.48 Mb critical interval on 
canine chromosome 7. By prioritizing candidate genes on the basis of biological 
plausibility, we found that a 15.7 kb deletion in BCAN, encoding the brain-specific 
extracellular matrix proteoglycan brevican, is associated with EFS. This represents a 
compelling causal mutation for EFS, since brevican has an essential role in the formation 
of perineuronal nets governing synapse stability and nerve conduction velocity. Mapping 
of the deletion breakpoint enabled the development of Multiplex PCR and Multiplex 
Ligation- dependent Probe Amplication (MLPA) genotyping tests that can accurately 
distinguish normal, carrier and affected animals. Wider testing of a larger population of 
CKCS dogs without a history of EFS from the USA revealed that carriers are extremely 
common (12.9%). The development of molecular genetic tests for the EFS microdeletion 
will allow the implementation of directed breeding programs aimed at minimizing the 
number of animals with EFS and enable confirmatory diagnosis and pharmacotherapy of 
affected dogs. 
 




 Episodic falling syndrome (EFS) is a well-recognized paroxysmal disorder found in 
Cavalier King Charles spaniels (CKCS). Episodes begin between fourteen weeks and 
four years of age and are triggered by exercise, stress, apprehension or excitement (1). 
Episodes are of variable frequency and severity but are characterized by progressive 
hypertonicity involving thoracic and pelvic limbs (Fig. 1a) until the dogs are ultimately 
immobilized in a characteristic 'deer-stalking' or 'praying' position (Fig. 1b). Stiffening of 
all four limbs during exercise can cause falling (Fig. 1c), although there is no loss of 
consciousness or cyanosis. Other clinical signs may include facial muscle stiffness, 
stumbling, a 'bunny-hopping' gait, arching of the back or vocalization. Curiously, 
between episodes, dogs appear to be completely normal neurologically. Spontaneous 
activity was not observed in muscle electrodiagnostic testing, ruling out myotonia 
congenita (2,3). Muscle biopsies are typically normal at the light microscopic level, 











Fig. 1. Clinical signs of episodic falling syndrome and muscle pathology. A 5-month-old female Cavalier 
King Charles spaniel presented with typical episodes of excitement or exercise-induced muscle stiffness (a, 
hypertonicity) that would involve all four limbs and progress to an usual 'deer-stalking' or 'praying' posture 
(b), eventually resulting in falling (c). While EFS muscle was normal histologically by light microscopy, 
electron microscopy (d) revealed that the sarcoplasmic reticulum (sr) appeared dilated and contained finely 
granular material compared to control muscle (e). Mitochondria (m) and myofibrils were normal in 
appearance in both tissues. Scale bars = 0.31 µm. 
 
 However, EFS has been linked to ultrastructural defects in skeletal muscle 
including dilatation and proliferation of the sarcoplasmic reticulum, mitochondrial 
swelling and degeneration (2,3). EFS has also been compared (4) with startle 
disease/hyperekplexia, typically characterized by noise- or touch-evoked neonatal 
hypertonicity due to defects in inhibitory glycine receptor (GLRA1, GLRB; 5,6) or 
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glycine transporter GlyT2 (SLC6A5) genes (7,8). However, a microdeletion in the GlyT2 
gene in Irish Wolfhounds results in severe neonatal muscle stiffness and tremor in 
response to handling (9), which is inconsistent with the observed clinical signs of EFS. 
Comparisons with startle disease may have been made because affected dogs often 
respond well to the benzodiazepine clonazepam (10), an effective anticonvulsant, 
anxiolytic and muscle relaxant that is the most effective known treatment for human 
hyperekplexia (11). However, the carbonic anhydrase inhibitor acetazolamide, used to 
treat certain types of human episodic ataxia (12) and hyperkalemic periodic paralysis 
(13), also appears to have therapeutic value in the treatment of EFS 
(http://www.cavalierhealth.org/episodic_falling).  
 
 Since a ten-year breeder-led investigation into the inheritance of EFS suggested an 
autosomal recessive mode of inheritance (http://cavalierepisodicfalling.com/), we used a 
genome-wide association strategy (14) to map the EFS locus to a defined region of canine 
chromosome 7. Candidate gene analysis enabled us to identify a microdeletion affecting 
the brevican gene (BCAN), confirm the deletion breakpoint and develop rapid genotyping 
tests for EFS. 
 
MATERIALS AND METHODS 
Light and electron microscopy:  
 For light microscopy, unfixed biopsies from the biceps femoris, vastus lateralis and 
triceps brachii muscles were collected from five affected CKCS dogs under general 
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anesthesia and frozen in isopentane pre-cooled in liquid nitrogen. Cryosections were cut 
(8 µm) and the following histochemical stains and reactions performed: hematoxylin and 
eosin, modified Gomori trichrome, periodic acid Schiff, phosphorylase, esterase, ATPase 
reactions at pH of 9.8 and 4.3, nicotinamide adenine dinucleotide-tetrazolium reductase, 
succinic dehydrogenase, acid phosphatase, alkaline phosphatase and oil red O. For 
electron microscopy, glutaraldehyde-fixed muscle specimens were post-fixed in osmium 
tetroxide, and dehydrated in serial alcohol solutions and propylene oxide prior to 
embedding in araldite resin. Thick sections (1 µm) were stained with toludine blue for 
light microscopy and ultrathin sections (60-90 µm) were stained with uranyl acetate and 
lead citrate for electron microscopy. 
 
Study cohort and DNA preparation:  
 Our study cohort comprised: EFS affected - 10 animals (6 from the USA, 2 from 
New Zealand and 2 from the UK); Obligate EFS carriers - 8 animals (2 from the USA, 6 
from New Zealand); Animals related to carriers or affected dogs - 21 animals (7 from the 
USA, 14 from New Zealand); Controls - CKCS with no EFS history - 14 animals (all 
from the USA). Genomic DNA was isolated from whole blood or buccal cells using the 
Gentra Puregene Blood Kit (QIAGEN, Valencia, USA). Additional DNA samples from 
155 CKCS with no clinical history of EFS and other pure bred-dogs were available from 
unrelated studies and other sources (e.g.  
Cornell DNA bank: http://www.vet.cornell.edu/research/dnabank/). 
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Genome-wide association mapping:  
 Thirteen CKCS genomic DNA samples isolated from blood (five cases, one 
obligate carrier and seven controls from the USA) were genotyped for 127,000 SNPs on 
the Affymetrix Canine SNP Array version 2 
(http://www.broadinstitute.org/mammals/dog/caninearrayfaq.html). The two main drivers 
for sample selection were: i) lack of relatedness - i.e., that the animals used for case- 
control analysis should not share a common ancestor within at least three generations and 
ii) the quality and quantity of genomic DNA available. Arrays were processed at the 
Clemson University Genomics Institute (http://www.genome.clemson.edu/) using the 
GeneChip human mapping 250K Sty assay kit (Affymetrix, Santa Clara, USA). The 
GeneChip human mapping 500K assay protocol was followed, but with a hybridization 
volume of 125 µl (14). Raw CEL files were genotyped using Affymetrix Power Tools 
software. SNPs having >10% missing data and ≥60% heterozygosity were removed. Data 
for 58,873 SNPs were formatted for PLINK (15) and case/control analyses with 100,000 
permutations were performed for five cases and seven controls (the obligate carrier was 
excluded from analysis). 
 
PCR and DNA sequencing:  
 PCR primers were designed to amplify exons and flanking splice donor, acceptor 
and branch-point sites, from gene structures derived in silico using the UCSC Genome 
Browser. For exon-specific primers for BCAN and HAPLN2 exon amplification see Table 
S1. PCR was performed using 50 ng genomic DNA as template and AccuPrime Pfx 
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SuperMix supplemented with betaine for 40 cycles of 94°C for 1 min, 60°C for 1 min, 
68°C for 1 min. PCR products were gel purified using a QiaQuick gel extraction kit 
(QIAGEN, Crawley, UK) for TOPO cloning (pCR4Blunt-TOPO; Invitrogen, Renfrew, 
UK). Sanger DNA sequencing was performed by DNA Sequencing & Services 
(MRCPPU, College of Life Sciences, University of Dundee, Scotland) using Applied 
Biosystems Big-Dye version 3.1 chemistry on an ABI 3730 automated capillary DNA 
sequencer. DNA sequences were analyzed using Sequencher 4.10 (Gene Codes 
Corporation, Ann Arbor, USA). For multiplex PCRs, the diagnostic primer set is: EFS1 
5'-aaggtcttacacctgcaatgaatag-3', EFS2 5'-agcaaatgtaaagtcctgtgaccat-3' and EFS3 5'- 
agttcacattgtgctctctctactg-3'. 
 
Multiplex ligation-dependent probe amplification (MLPA) analysis:  
 Five MLPA probe sets were designed corresponding to the promoter region (PR) 
and exons 1 (5' UTR), 2, 3 and 4 of the canine brevican gene (BCAN; NC_006589 on 
chromosome 7; Table S2). Criteria for MLPA probe design were as previously described 
(Schouten et al. 2002). A control probe pair was designed to recognize an unrelated gene 
(CFTR: NC_006596 on chromosome 14). Probes generated amplification products 
ranging in size from 88 to 115 bp and had annealing temperatures higher than 70°C as 
recommended in RAW Probe software (MRC-Holland, Amsterdam, The Netherlands) 
using standard MLPA conditions (Schouten et al. 2002). PCR products were analyzed on 
an ABI 3130XL capillary electrophoresis apparatus (Applied Biosystems, Lennik, 
Belgium). Normalization of BCAN- specific probe signals was performed by dividing the 
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values obtained by the combined signal of the control probes. 
 
RESULTS 
Light and electron microscopy:  
 Unfixed cryosections of muscle biopsies were histologically normal at the light 
microscopic level with no abnormalities detected following any of the histochemical 
stains and enzyme reactions employed. Contrary to previous reports (2,3) electron 
microscopy revealed normal myofibrillar and mitochondrial morphology, although 
swelling of the sarcoplasmic reticulum was confirmed (Fig. 1d,e). 
 
Genome-wide association mapping and candidate gene resequencing:  
 A total of 17 single nucleotide polymorphisms (SNPs) were associated with EFS 
(Praw values ≤ 0.0001) (Table S3). The most significant result was for SNP 43389066 
(Praw = 5.10×10-7, Pgenome = 2.68×10-3) (Fig. 2a). All significant SNPs were located 
within a 7.2 Mb region on canine chromosome 7. A critical interval of 3.48 Mb (from 
7.42838021 to 7.46320904) was delimited by recombinant chromosomes identified in 
one EFS dog and an obligate carrier (Fig. 2b). In order to identify the mutation associated 
with EFS, we prioritized several genes for resequencing based on biological plausibility. 
These encoded ligand-gated or voltage-gated ion channels (CHRNB2, HCN3, KCNN3), 
mitochondrial (MRPL24, MTSO1, MTX1, SLC25A44), muscle (MEF2D, TPM3) or brain-
expressed proteins (ARHGEF11, BCAN, GBA, HAPLN2, NES, RIT1, SYT11, UBQLN4). 
Curiously, amplification of BCAN exons 1, 2 and 3 consistently failed with multiple 
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primer sets when using genomic DNA from affected animals, while DNAs from carriers 
and unaffected dogs amplified reliably (Fig. 3a). Because no preferential amplification 
was observed for the adjacent gene, HAPLN2 - encoding hyaluronan and proteoglycan 
link protein 2/Bral1 (16-18) - we suspected that a microdeletion affecting BCAN 






Fig. 2. Mapping the episodic falling syndrome locus. (a) –log10 of Praw values (Y axis) for genome-wide 
association using five EFS and seven control dogs are plotted for each chromosome (X axis). A single 
major signal was detected on chromosome 7. (b) A 3.48 Mb critical interval encompassing SNP 43389066 




Deletion breakpoint identification and development of diagnostic tests:  
 Further primer walking experiments enabled us to clone and sequence a DNA 
fragment containing the deletion breakpoint and develop a multiplex PCR assay that 
distinguishes between affected, carrier and normal dogs (Fig. 3b). Sequence analysis of 
the breakpoint amplicon revealed a 15.7 kb microdeletion starting 1.56 kb downstream of 
HAPLN2, encompassing BCAN promoter elements and exons 1 (5' untranslated), 2 and 3, 
finishing 85 bp downstream of BCAN exon 3 (Fig. 3c). The microdeletion amplicon also 
contained a 6 bp inserted sequence (GGCCTT; Fig. 3d) typical of deletions resulting 
from non-homologous end joining (NHEJ) or microhomology-mediated end joining 
(MMEJ). Several regions of microhomology (1-7 bp) were identified in a 30 bp region 
encompassing the breakpoints (Fig. 3e). Interestingly, 5 of 6 bp of the reverse 
complemented inserted sequence aligns to the largest region of microhomology. We also 
noted an abundance of short interspersed element (SINE) insertions at the 5' end of the 
deleted sequence, which could cause the formation of secondary structures that facilitate 
chromosomal rearrangement (19). We also detected the presence of the BCAN 










Fig. 3. (a) PCR panels for BCAN exons 1–4 showing that amplicons for the first three exons of the 
brevican gene can be generated from genomic DNA from normal (+/+) or obligate carrier (+/-) samples, 
but cannot be amplified from an equivalent EFS sample (-/-). By contrast, BCAN exon 4 can be amplified 
from all genotypes. (b) Multiplex PCRs with primers flanking the 15.7 kb BCAN microdeletion allowed 
simultaneous detection of the wild-type BCAN allele (primers EFS1 + 2, 393 bp) in normal (+/+) or EFS 
carrier (+/-) animals, while the EFS allele (primers EFS1 + 3, 273 bp) is detected in both EFS carrier and 
affected (-/-) dogs. Note that the two carriers shown have both wild-type and EFS amplicons, as expected 
for a heterozygous genotype. (c) Schematic diagram showing the genomic organization of the HAPLN2 
and BCAN, the position of the deletion (grey shading) and EFS1-3 primers. (d) Sequence spanning the 
BCAN deletion breakpoint, showing an additional non-homologous inserted sequence indicated by arrows. 









Fig. 4. Position of the EFS microdeletion. Genomic DNA from canine chromosome 7 highlighting exons 
1–4 of BCAN and the position of the 15.7 kb EFS microdeletion (grey shading). 
 
 This quantitative analysis also confirmed that EFS is associated with a loss of 
BCAN promoter/regulatory elements and exons 1-3 in heterozygous carriers and 






Fig. 5. Confirmation of the BCAN microdeletion using Multiplex Ligation-dependent Probe Amplification. 
(a) MLPA analysis revealed robust detection of a control probe (CFTRa) and probes for the BCAN 
promoter/regulatory region (PR) and exons 1–4. However, signals for probes PR and exons 1–3 were 
reduced by 46–55% in heterozygous (+/-) animals and abolished in homozygous animals (-/-), consistent 
with a loss of probe binding sites in genomic DNA. 
 
Rapid genotyping using multiplex genotyping in different dog populations:  
 To assess the prevalence of the EFS microdeletion, we used our multiplex PCR 
assay to test several CKCS populations and other dog breeds (Table 1). All affected dogs 
in our study cohort - from the UK (n = 2), USA (n = 6) and New Zealand (n = 2), were 
homozygous for the BCAN microdeletion. In addition, all obligate carriers were 
heterozygous (n = 2 from the USA and n = 6 from New Zealand). In animals related to 
affected dogs, we found 9 normal animals and 10 carriers. Interestingly, in this group,  
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Genotypes revealed by multiplex PCRs were determined as described in Materials and methods. Dogs were 
evaluated on the basis of available clinical data and placed into one of the phenotype categories above. 
Note that all clinically affected animals were homozygous for the BCAN deletion, whilst obligate carriers 
were heterozygous. As well as wild-type animals and carriers of the BCAN deletion, two dogs homozygous 
for the BCAN deletion, which were not reported to have classical clinical signs of EFS, were detected in a 
cohort of animals related to known EFS dogs. Carriers were also detected in CKCS with no history of EFS, 
but not in control DNA samples from 54 other dog breeds including: Airedale terrier, Akita Basenji, 
American Staffordshire Terrier, American Cocker Spaniel, American Eskimo Dog, Australian Shepherd, 
Akita Basenji, Bernese Mountain Dog, Bluetick Coonhound, Border collie, Boston Terrier, Boxer, Boykin 
Spaniel, Briard, Bull Mastiff, Bulldog, Cairn Terrier, Catahoula Leopard Dog, Chihuahua, collie, 
Dachshund, Dalmatian, English Setter, English Springer Spaniel, Flat Coated Retriever, German Shepherd, 
Giant Schnauzer, Golden Retriever, Great Dane, Havanese, Siberian Husky, Irish Setter, Italian Greyhound, 
Labrador Retriever, Miniature Pinscher, Miniature Poodle, Miniature Schnauzer, New Guinea Singing 
Dog, Norwegian Elkhound, Petit Basset Griffon Vendeen, Pomeranian, Portuguese Podengo Pequeno, Pug, 
Pyrenean Shepherd, Schipperke, Shetland Sheepdog, Swedish Vallhund, Tibetan Terrier, Toy Fox Terrier, 
Weimaraner, Welsh Terrier, West Highland White Terrier, Wire Fox Terrier and Yorkshire Terrier. Where 
possible, two unrelated dogs were tested for each breed. 
 
two dogs without a classical clinical history of EFS were homozygous for the 
microdeletion. Lastly, in dogs with no known clinical history of EFS sourced from the 
USA, the carrier frequency was 12.9% (20/155) suggesting that the EFS microdeletion is 
present at a high frequency in this population. Notably, the mutation was not detected in 






 The genomic architecture of pure-bred dog lines is ideal for the identification of 
loci responsible for autosomal recessive traits using genome-wide association mapping 
(14,21). In this study, we demonstrate that this technique can be used successfully on 
minimal samples sets, since we located the EFS locus using DNA samples from only five 
affected and seven breed-matched control dogs. Since a homozygous haplotype spanning 
6.35 Mb was identified in affected animals, it is questionable whether further SNP typing 
would have generated additional useful data. In fact, a single recombination event in an 
obligate carrier allowed us to narrow the critical interval to 3.48 Mb. This region 
contained >100 genes, including ligand-gated ion channels, K+ channels, transporters, 
mitochondrial proteins and several genes known to be involved in neurological disorders 
in humans. For example, mutations in CHRNB2 are associated with nocturnal frontal lobe 
epilepsy (22) and TPM3 mutations are associated with nemaline myopathy (23). 
However, many of these genes were rapidly eliminated as candidates due to either: i) 
poor correlation of EFS clinical signs with the equivalent human disorders or ii) 
systematic resequencing of the genes. Consistent with the unique clinical signs observed 
in affected dogs, we discovered that a homozygous microdeletion affecting BCAN is 
associated with EFS in CKCS dogs, confirming that this disorder is inherited in an 
autosomal recessive manner. This mutation was not detected in control DNA samples 
from 54 other dog breeds, confirming the unique nature of this genomic rearrangement. 
 
 Brevican belongs to the lectican family of aggregating extracellular matrix (ECM) 
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proteoglycans, which comprises aggrecan, brevican, neurocan and versican. Although 
mutations in the aggrecan and versican genes (ACAN: 15q26.1 and VCAN: 5q14.2-14.3) 
have been linked to different connective tissue disorders (24-26; Fig. 6), no mutations in 
the brevican or neurocan genes (BCAN: 1q23.1 and NCAN: 19p13.11) have been 
identified to date. Brevican and neurocan are highly expressed in the central nervous 
system, where they are found in specialized extracellular matrix structures called 
perineuronal nets that play a role in cell adhesion, migration, axon guidance and neuronal 
plasticity (27).  
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Fig. 6. Modular organization of the superfamily of hyaluronan-binding proteins and associated disorders. 
Mutations in ACAN, encoding aggrecan—a major component of cartilage, have been implicated in 
spondyloepiphyseal dysplasia type Kimberley (24) and familial osteochondritis dissecans (25). Mutations 
in VCAN, encoding versican, are associated with Wagner syndrome and erosive vitreoretinopathy, 
disorders affecting the connective tissue of the eye (26). Modified from (28). 
 
 
Brevican, versican, HAPLN2/BRAL1, tenascin-R and phosphacan are also present at the 
nodes of Ranvier on large diameter myelinated axons (18,29) where cations are 
accumulated and depleted in the local extracellular nodal region during action potential 
propagation. The ECM complex at nodes of Ranvier is thought to play a pivotal role in 
maintaining a local microenvironment, acting as a diffusion barrier for K+ and Na+ 
around the perinodal extracellular space (17,18). Thus, disruption of ECM complexes 
governing synapse stability and nerve conduction velocity are likely to underlie the EFS 
phenotype. Certainly, since EFS appears to result from a central nervous system rather 
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than a muscle defect, the associated sarcoplasmic reticulum pathology is likely to be a 
secondary manifestation of muscle overstimulation (30). Interestingly, BCAN knockout 
mice were not reported (27) to have a phenotype similar to EFS - although an increased 
grip-strength was noted, which could be indicative of increased muscle tone. However, it 
is questionable whether current mouse phenotyping tests will reveal neurological 
disorders evoked by strenuous exercise, stress, apprehension or excitement, since these 
conditions are generally avoided in mouse care. It is also noteworthy that EFS clearly 
shows variable age of onset and penetrance. For instance, we identified two dogs that 
were homozygous for the BCAN microdeletion that had not shown classical clinical signs 
of EFS in the presence of their owners. Interestingly, similar findings were reported for 
the dynamin (DNM1) mutation (p.R256L) underlying exercise-induced collapse in 
Labrador retrievers (31). It is plausible that these dogs have not been exposed to 
sufficient exercise or excitement to trigger an episode, or that genetic or environmental 
modifying factors (e.g. diet) affect the onset of these disorders. However, it is notable that 
one of the two asymptomatic dogs in our study was described as 'exercise resistant' by 
their owner, suggesting that adaptive behavior may occur in dogs that are homozygous 
for the BCAN microdeletion. It must also be emphasized that such non-classical cases are 
rare - we did not find a single dog that was homozygous for the BCAN microdeletion in 
155 CKCS with no clinical history of EFS (Table 1). 
 
 In summary, we have shown that an inactivating microdeletion affecting BCAN is 
associated with EFS in CKCS dogs. Identification of the deletion breakpoint has allowed 
 45 
the development of diagnostic tests that have revealed a high prevalence of carriers 
(12.9%) in clinically unaffected dogs from the USA. These genetic tests (available via 
Laboklin: http://www.laboklin.co.uk/) will enable future identification of heterozygous 
animals (which have no discernable phenotypic difference to wild-type animals) allowing 
directed breeding programs to be implemented, and confirmatory diagnosis and 
appropriate pharmacotherapy of affected animals. Since this also represents the first 
report of a genetic disorder involving a neuronal-specific ECM proteoglycan, we suggest 
that BCAN and NCAN should be considered as candidate genes for genetic analysis in 
unresolved cases of human disorders with similar clinical presentations to EFS, such as 
paroxysmal exercise-induced dyskinesias (32) or episodic ataxias (12). 
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ABSTRACT  
The German shepherd dog (GSD) is an extremely popular working and companion breed 
for which over 50 hereditary diseases are documented. Herein, we generated SNP profiles 
for 197 GSDs using the Affymetrix v2 canine SNP array and employed a genome-wide 
association strategy to find loci associated with four diseases: pituitary dwarfism, 
degenerative myelopathy (DM), congenital megaesophagus (ME), and pancreatic acinar 
atrophy (PAA). A strongly associated locus on chromosome 9 was detected for pituitary 
dwarfism, and is proximal to a plausible candidate gene, LHX3. Results for DM confirm 
a major locus encompassing SOD1, in which an associated point mutation was previously 
identified, but do not suggest significant modifier loci. Several SNPs on chromosome 12 
were found to be associated with ME and a 4.7 Mb haplotype block was identified. 
Analysis of additional affected dogs for a SNP within the haplotype provides further 
support for the association. Results for PAA indicate more complex genetic 
underpinnings. Loci on 23 chromosomes reached genome-wide significance. No major 
locus was detected and only two weakly associated haplotype blocks, on chromosomes 7 
and 12, could be detected. These data suggest that PAA may be governed by multiple loci 








Shepherds and hounds were the earliest dog breeds developed to serve in 
specialized roles (1). The German shepherd dog (GSD), for which the standard was 
originally developed in 1899, was bred for utility and intelligence and to be a multi-
purpose servant of humans (1). Aptitude, temperament, structural efficiency and other 
natural skills were selected for over aesthetic traits. Today, the GSD is among the most 
common breeds trained in specialized jobs for the military, law enforcement, and 
service/assistance programs (2). The GSD is also an extremely popular companion, 
ranking second in breed registration statistics reported by the American Kennel Club in 
2010. Unfortunately, despite a large population size and outbreeding practices, over 50 
hereditary diseases plague the GSD (3). 
 
Pituitary dwarfism is a rare disease of GSDs characterized by an abnormally small 
body structure due to a deficiency in pituitary growth hormone. Dogs appear to be normal 
at birth, but signs of slowed growth are usually evident by 2-3 months of age. There are 
no treatments available for dogs and their lifespan may be significantly shortened. 
Pituitary dwarfism in the GSD is inherited in an autosomal recessive fashion (4). 
Combined pituitary hormone deficiency (CPHD) in the human is a type of growth 
hormone deficiency that results from a decrease in several hormones necessary for 
pituitary development. Mutations that cause congenital CPHD in the human have been 
identified in several transcription factors important for pituitary development, such as 
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PIT1, PROP1, LHX3, LHX4, HESX1 (5). Sequencing of PIT1 (6), PROP (7), LHX4 (8), 
and LIFR (9), did not reveal any causative variants. 
 
Degenerative myelopathy (DM) is a late-onset neurodegenerative disease 
characterized by ataxia and weakness in the hind limbs. Symptoms of DM worsen over 
time, either steadily or in phases, and eventually result in complete paraplegia. In some 
cases, DM may progress up the spinal cord and cause forelimb weakness and respiration 
difficulties (10). Age of onset is generally between 5 and 14 years, with a mean onset of 9 
years (11). The clinical signs observed in DM are general indicators of spinal cord 
disorders; definitive diagnosis for DM can only be made by histopathological 
examination of spinal cord tissue postmortem (12).  Most owners of affected dogs elect 
euthanasia within several months of the onset of clinical signs (13). DM is most prevalent 
in the GSD (12). A recessive missense mutation in SOD1 is associated with DM in 
several breeds, including GSDs (14). DM has been proposed to be a large-animal model 
for amyotrophic lateral sclerosis (ALS). Approximately 20% of hereditary ALS cases are 
attributed to mutation of SOD1 (15). 
 
Congenital idiopathic megaesophagus (ME) is characterized by dilation and 
hypomotility of the esophagus. The result of these anomalies is regurgitation several 
minutes to hours after eating. Regurgitation episodes may occur as often as several times 
a day or as infrequently as once every few days. Symptoms for congenital ME typically 
begin around five weeks of age after weaning onto solid food. Affected puppies are 
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malnourished, show a general failure to thrive, and are at risk for aspiration pneumonia. 
Diagnosis of ME is achieved by standard X-rays and/or fluoroscopy (barium swallow) 
(16). ME is typically treated by feeding a high calorie, liquid diet from a raised dish (16). 
Mortality is high in affected neonates. Many survivors require lifelong management of 
the disorder, but other cases resolve by four to six months of age (17). ME is prevalent in 
the GSD, Great Dane, miniature schnauzer, Rhodesian ridgeback, dachshund, and wire 
fox terrier breeds, and is also reported to occur at lower frequencies in many other breeds 
(18). Several loci are thought to be responsible for ME in the dog (17), but the mode of 
inheritance in the GSD has not been investigated. 
 
Pancreatic acinar atrophy (PAA) is an autoimmune disease characterized by the 
selective atrophy of the acinar cells of the pancreas, which produce and secrete digestive 
enzymes (19). PAA is the most common cause of exocrine pancreatic insufficiency (EPI) 
in the dog (20) and is diagnosed through histopatholgic examination (21). EPI is 
diagnosed through measurement of serum canine trypsin-like immunoreactivity (cTLI), 
with concentrations < 2.5 µg/L diagnostic for EPI (22). Ninety-six percent of affected 
dogs present with clinical signs of EPI, including weight loss, increased appetite, and soft 
stools, by five years of age (20,23). Affected dogs can be treated with pancreatic enzyme 
supplements, although dogs with EPI are often euthanized because of the expense of 
treatment or poor treatment response (24,25). PAA is a disorder that is widespread in the 
GSD population, but also affects many other breeds including collies (26,27). Recent 
inheritance studies in the GSD show that EPI is likely a polygenic disorder (28).  
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 The development of high-throughput genotyping technologies has facilitated the 
discovery of genes responsible for simple and complex phenotypes of the dog (29,30). 
The population structure of the dog is particularly well-suited for association mapping 
techniques because genetic bottlenecks during breed formation created large blocks of 
linkage disequilibrium within breeds (29). Reported here is the use of a large cohort of 
GSDs to investigate the afore- mentioned four diseases that segregate in the population. 
Genetic profiles for 197 GSDs were generated using the Affymetrix v2 canine SNP array. 
Using a single data set, we carried out genome-wide association studies (GWAS) to 
identify risk loci for four diseases of the GSD. 
 
MATERIALS AND METHODS 
Sample Collection 
Samples were recruited from purebred GSDs that had been diagnosed with EPI, 
DM, or ME through standard veterinary diagnostic procedures. DM cases were diagnosed 
by veterinary neurologists. Dogs were considered to have congenital idiopathic ME if 
they did not have conditions that cause secondary ME, such as persistent right aortic arch 
and myasthenia gravis. Purebred GSDs collected as controls were at least six years of age 
and, to the owners’ knowledge, had no immediate family members affected with EPI, 
DM, or ME. Cases and controls were selected to have as few close relatives (within three 
generations) in the study cohort as possible. Samples were acquired from the United 
States, Canada, Germany, and the Netherlands. Owners were asked to report all known 
hereditary conditions, as well as coat color phenotypes.  
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 Whole blood or buccal swabs were submitted by dog owners. Blood samples were 
collected by owners’ private veterinarians. All samples were collected in accordance with 
protocols approved by the Clinical Research Review Committee (CRRC No. 07-04) at 
Texas A&M University and the Clemson University Institutional Review Board 
(IBC2008-17). Genomic DNA was isolated using the Gentra Puregene Blood Kit 
(Qiagen, Valencia, CA, USA). Serum samples were collected from all EPI cases and 
controls and submitted to the Gastrointestinal Laboratory at Texas A&M University for 
measurement of cTLI to confirm clinical status. Concentrations ≤2.5 µg/L were 
considered diagnostic for EPI. Control dogs had concentrations ≥5.7 µg/l. All EPI cases 
were assumed to result from PAA, but tissue samples were not available to differentiate 
EPI due to PAA or another cause of EPI. 
 
GWAS 
SNP genotypes were generated using the Affymetrix Canine SNP Array version 2 
(http://www.broadinstitute.org/mammals/dog/caninearrayfaq.html). Arrays were 
processed at the NHGRI or Clemson University Genomics Institute 
(http://www.genome.clemson.edu/) using the GeneChip human mapping 250K Sty assay 
kit (Affymetrix, Santa Clara, USA). The GeneChip human mapping 500K assay protocol 
was followed, but with a hybridization volume of 125 µl (29). Raw CEL files were 
genotyped using Affymetrix Power Tools software. SNPs having >10% missing data and 
≥60% heterozygosity were removed from the data set. Case/control analyses were 
performed on the 48,415 SNPs from the ‘‘platinum’’ set using PLINK (31), with Praw < 
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0.0001 considered significant. To determine Pgenome values (EMP2), permutation 
testing (100,000) was performed for PAA, DM, and ME analyses using PLINK. A less 
conservative correction, Benjamini–Hochberg, was also performed (32). Analysis of 
population stratification in 197 GSDs was conducted using identity-by-state clustering 
and multidimensional scaling in PLINK. The data, in a reduced representation, were 
plotted in two dimensions: principal components 1 and 2. 
 
Genotyping of SNP 12.60274687 
 Primers flanking the SNP 12.60274687 were designed: forward: 5’ -
TGAGCACACAGAGGTGAGACAT-3’ and reverse: 5’ -
CAGTGGGAGGGTTTAGGAAGAGAT-3’ . SNP 12.60274687 was amplified for 35 
additional ME dogs using Thermo ReddyMix (Thermo Fisher Scientific, Waltham, MA, 
USA) following the recommended proto- col. Thermal cycling conditions were as 
follows: 95°C for 15 min; 14 cycles of 95°C for 30 s, 62°C for 1 min (decreasing 0.5°C 
each cycle), 72°C for 1 min; 20 cycles of 95°C for 30 s, 55°C for 1 min, 72°C for 1 min; 
72°C for 10 min. PCR amplicons were analyzed by electrophoresis on agarose gels. 
Products were purified by adding 0.5 unit exonuclease I (New England Biolabs, Ipswich, 
MA, USA) and 0.25 unit of shrimp alkaline phosphatase (Promega, Madison, WI, USA) 
and incubating for 30 min at 37°C followed by 20 min at 80°C. Nucleotide sequencing 
was accomplished using the Big Dye Terminator version 3.1 Cycle Sequencing kit 
(Applied Biosystems, Carlsbad, CA, USA). Products were purified using Spin-50 mini 
columns with water (BioMax, Inc., Arnold, MD, USA) and resolved on an ABI Prism 
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3730 Genetic Analyzer (Applied Bio- systems). Sequences were analyzed to determine 
SNP genotypes. Odds ratios (OR), critical intervals, and x2 tests were calculated to assess 





 In total, 197 GSD samples were acquired from the United States, Canada, 
Germany, and the Netherlands. Two GSDs were affected with EPI and DM. One GSD 
was affected with EPI and ME. Principal component analysis with PLINK showed no 
evidence for population stratification within our GSD cohort (n = 197) using all 
‘‘platinum’’ SNPs (Fig. 1). To validate both our genotype data and statistical approach, 
we first mapped a positive control trait. Ten dogs in the study cohort had white coats, a 
recessive trait caused by the e allele of MC1R in the GSD (33). GWAS using 197 GSDs 
(10 cases, 187 controls) reveals a strongly associated region encompassing MC1R on 
chromosome 5 (Fig. 2a). SNP 5.66900853, the most significant result (Praw = 3.61 9 10
-
22), is located approximately 208 kb adjacent to the E locus. The lack of subpopulations, 





Fig.1 Principal component analysis of the GSD cohort shows all 197 dogs clustering together. The x axis is 
principal component 1 and the y axis is principal component 2. Two individuals that appear apart from the 
main grouping have the largest proportion of missing data (22.7 and 22.4% overall, compared to the 





Fig. 2 Manhattan plots showing the results for GWAS using 48,415 SNPs. The genome-wide P values (-
log10 P) for each SNP are plotted against position on each chromosome. a Ten white GSDs versus 187 
nonwhite GSDs show a strong association on chromosome 5. b Four pituitary dwarf GSDs versus 193 






Four dogs in our control population have pituitary dwarfism. GWAS using these 
four cases and 193 normal-sized controls, showed a major region of association on 
chromosome 9 (Fig. 2b). Within this region, all four pituitary dwarfs were homozygous 
for a haplotype extending from SNP 9.52031784 to SNP 9.54102643. The haplotype was 
never observed in the homozygous state among the control dogs, and was heterozygous 
in 15 control dogs. The most significant result, SNP 9.53350831 (Praw = 2.04 × 10-10), is 
located approximately 764 kb from a candidate gene, LHX3.  
 
Degenerative myelopathy 
GWAS with 100K permutations for DM were carried out using all cases collected 
(n = 15) and control dogs that were at least eight years of age and had exhibited no 
clinical signs of DM (n = 69). The two most significant results were for SNPs 
31.28909487 (Praw = 8.51 × 10-06, Pgenome = 0.1461) and 31.30528862 (Praw = 5.59 × 10-05, 
Pgenome = 0.5771) (Fig. 3a). These SNPs on chromosome 31 are located 650 kb upstream 
and 965 kb downstream of SOD1, respectively. Evaluation of genotypes in this region 
showed that only four of the 15 cases were homozygous at both loci. Five cases were 
homozygous for the associated allele of SNP 31.30528862, while nine cases were 
homozygous for the associated allele of SNP 31.28909487. In the control population, six 
of 69 GSDs were also homozygous for the same allele of SNP 31.28909487. A third 
significant result was detected on chromosome 10 for SNP 10.64801770 (Praw = 6.06 × 
10-05, Pgenome = 0.6066). 
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Fig. 3 GWAS using 48,415 SNPs with 100,000 permutations. The genome-wide adjusted P values (–log10 
P) for each SNP are plotted by chromosome. a Fifteen GSDs with DM versus 69 healthy control GSDs. b 
Nineteen GSDs with ME versus 177 healthy control GSDs. c One-hundred GSDs with PAA versus 79 




GWAS with 100,000 permutations were carried out using 19 cases and 177 
control dogs. Significant results were obtained for 14 SNPs on eight different 
chromosomes (Fig. 3b). Of the 14 significant results, three were located within an eight 
Mb region on chromosome 12. Five other SNPs within this region are approaching 
significance. The most significant of these is SNP 12.60274687 (Praw = 1.49 × 10-5, 
Pgenome = 0.3099). Analysis of genotypes for this SNP revealed that all affected dogs share 
a common allele (frequency = 0.83) that was less prevalent among control dogs 
(frequency = 0.46). To further investigate this finding, 35 additional ME GSDs were 
collected and genotyped for the SNP. Genotype frequencies and odds ratios for SNP 
12.60274687 are shown in Table 1. Further analysis of genotypes on chromosome 12 
revealed a haplotype block extending 4.7 Mb that is present in all affected dogs. 
 
 
Pancreatic acinar atrophy 
GWAS with 100,000 permutations were carried out using 100 cases and 79 
control dogs (Fig. 3c). Significant Praw values were obtained for 50 SNPs on 23 
chromosomes (Supplementary Table 1). Chromosome 12 harbors seven significant SNPs, 
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three of which are found in a cluster: 12.3781476, 12.3845215, and 12.4698937. 
Chromosome 7 harbors six significant SNPs, four are found in a cluster: 7.11222056, 
7.12305239, 7.12310223, 7.12424701. On ten chromosomes, only one SNP each is 
strongly linked with PAA. On the remaining 11 chromosomes, no two strongly associated 
SNPs were located within 5 Mb of each other and no common haplotypes are detected. 




Autosomal recessive traits of the dog can be mapped using remarkably small 
numbers of cases (34,35). In this study, a mere four cases were sufficient to detect strong 
linkage to chromosome 9 and define a two Mb pituitary dwarfism haplotype. While the 
critical interval harbors more than 40 loci, one gene is an intriguing candidate: LHX3, a 
LIM homeodomain transcription factor vital for pituitary and motor neuron development 
(36). Genetic variations within LHX3 cause CPHD in humans (37,38). Although some 
mutations in LHX3 are also associated with a rigid cervical spine, mental retardation, and 
deafness (37,39,40), the GSD pituitary dwarfs do not have clinical signs that indicate 
nervous system involvement (41). In mice, complete loss of LHX3 is lethal (42), but 
mutations within the gene cause a dwarfism phenotype (43,44). 
 
 Recently, Voorbij et al. announced the availability of a genetic test for pituitary 
dwarfism in the GSD (45), but information regarding the gene or mutation has not been 
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published to date. Dwarfism in the GSD is reportedly rare and utilization of the genetic 
test could facilitate rapid elimination of the phenotype. Our data are surprising because 
the frequency of the two Mb haplotype in our control dogs is four percent, suggesting a 
roughly eight percent carrier frequency in the general population. Moreover, this estimate 
is likely low because only dogs having the complete two Mb haplotype were considered 
to be carriers, thereby excluding dogs with partial overlapping haplotypes that may have 
the causative mutation. 
 
Degenerative Myelopathy 
 DM is a devastating disorder of GDSs that has been difficult to eradicate from the 
breed, in part because of a late age of onset and poor diagnostic tools. We identified two 
SNPs on chromosome 31 that were strongly associated with the DM phenotype. The 
SNPs flank SOD1, the gene in which Awano et al. (14) identified an E40K missense 
mutation in DM-affected dogs from several breeds. The authors propose that the mutation 
causes DM in an autosomal recessive fashion (14). In our study, only nine of 15 cases 
were homozygous for the more tightly linked SNP, suggesting that either our relaxed 
diagnostic criteria (dogs were not diagnosed postmortem) may have led to the inclusion 
of dogs that were misdiagnosed, or that heterozygosity for the mutation can produce an 
affected phenotype. Recombination between the SNP, located 652 kb from the SOD1 
exon two mutation, may also be a factor (five cases were heterozygous). Only six of 69 
dogs in our control population were homozygous for the SNP, corresponding to nine 
percent affected controls. Similarly, Awano et al. (14) reported that six percent of GSD 
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breed controls were homozygous for the SOD1 mutation. The high frequency of 
clinically normal, aged controls that are homozygous for the mutation suggests the 
involvement of modifier loci and/or environmental factors. In our analysis, a second 
significant locus is detected on chromosome 10 and is supported by six proximal SNPs 
with P values approaching significance (< 0.00086). Awano et al. (14) detected weaker 
signals of association on chromosomes 6, 18, 20, and 35. Our data do not support regions 
of association on chromosomes 18 and 35, but do show modest signals on chromosomes 
6 and 20.  
 
Megaesophagus 
 The mode of inheritance of ME has not been previously investigated in the GSD, 
but it has been suggested that the frequent occurrence of affected puppies born to 
clinically normal parents serves as evidence for a recessive mutation. In this work we 
successfully mapped two simple autosomal recessive traits with ten and four cases and a 
complex recessive trait with 15 cases. GWAS using 19 dogs with ME, however, did not 
yield a single, strong region of association. Rather, minor associations were detected on 
eight different chromosomes. It is, therefore, unlikely that ME is inherited in an 
autosomal recessive fashion in the GSD. Similarly, evaluation of inheritance patterns of 




 A locus on chromosome 12 is the only one to reach genome-wide significance 
and have supporting proximal SNPs (8 SNPs having Praw values <0.00014). To verify an 
association, 35 additional ME GSDs were collected and genotyped for the most strongly 
associated SNP in this region. In total, 53 of 54 ME cases were heterozygous or 
homozygous for the associated allele, which occurs at a significantly lower frequency in 
the control population. These data are consistent with an autosomal dominant mode of 
inheritance, with incomplete penetrance and/or modifying loci. On the other hand, it is 
also conceivable that the allele is fully penetrant but that the control population includes 
dogs with undetected ME. ME varies in severity and can resolve completely after a few 
months, making detection of mild cases difficult. 
 
 The dilation and lack of muscle contraction in the esophagus is thought to be a 
neurological defect rather than a muscular defect (16). The associated haplotype on 
chromosome 12 harbors approximately 12 genes, several of which are expressed in the 
nervous system. Additional genome-wide SNP analyses in ME GSDs are necessary to 
confirm this association. 
 
Pancreatic acinar atrophy 
Fifty SNPs, representing 45 loci, exceeded genome-wide significance thresholds 
for association with PAA. A majority of significant SNPs map to chromosome 12, 
although only three SNPs on the chromosome support the same locus. These SNPs map 
to the dog leukocyte antigen (DLA) complex in the centromeric region of the 
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chromosome. The association of this region with PAA is consistent with the autoimmune 
component of the disease. Previous work, we showed that pancreases from GSDs with 
PAA have increased expression of DLA-88 (46). DLA-88 is the most highly polymorphic 
class I locus of the DLA complex. DLA class II loci are associated with diabetes mellitus, 
anal furunculosis, hypoadrenocorticism, necrotizing meningoencephalitis, and several 
other autoimmune disorders of the dog (47-50). Canine systemic lupus erythematosus is 
also reported to be associated with alleles of the DLA class II loci, and GWAS revealed 
five additional associated loci (51,52). The current SNP data, together with previous 
expression data, suggest that the DLA region may harbor a genetic risk factor for the 
development of PAA. Further investigation of the DLA loci is planned. A second region 
of interest is located on chromosome 7, which has four strongly associated SNPs located 
within a 1.2 Mb region having 11 genes. None of these genes is known to be involved in 
autoimmune disorders, although several are expressed in acinar cells. 
 
The data reported here suggest that PAA may be governed by multiple loci with 
small effects, or it may be a heterogeneous disorder. Although PAA was thought to be a 
simple autosomal recessive disorder (53,54), the results of a recent test mating between 
two GSDs with PAA indicate more complex genetic underpinnings (28). The study 
monitored the cTLI scores for the resulting litter of six over the course of the dogs’ lives 
(8–13 years) and the pancreas for each dog was examined at necropsy. Only two of the 
six dogs in the litter were diagnosed with PAA (28). Similarly, the clinical presentation of 
PAA is inconsistent. The age of onset is variable within families, with diagnoses made in 
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puppies and adult dogs alike. The severity of clinical signs also varies, with some dogs 
responding better to traditional treatment regimens than others. To further complicate the 
matter, some GSDs never exhibit clinical signs, despite serum cTLI concentrations that 
are diagnostic for EPI. Variability in age of onset and clinical signs may be an indicator 
of genetic heterogeneity. Although PAA is the predominant cause of EPI in dogs, chronic 
pancreatitis, pancreatic cancer, and other underlying medical conditions may also cause 
EPI. 
 
 Variation between processed arrays, a so-called ‘‘batch effect,’’ can cause spurious 
associations (55). The abundance of isolated SNPs detected in our GWAS for PAA is 
suggestive of such artifacts. However, principal component analysis does not reveal 
subpopulations that indicate a batch effect. Furthermore, no population stratification is 
detected between PAA cases and controls (Supplementary Fig. 1). In addition, we 
included only the robust ‘‘platinum’’ SNPs in our analysis to minimize artifacts from 
incorrect genotype calls. 
 
In this study, we used data from a single cohort of GSDs to identify major loci 
associated with pituitary dwarfism, DM, and ME. Our data also reveal that the genetics 
underlying PAA are highly complex. Candidate loci identified herein provide immediate 
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ABSTRACT  
 Araucana chickens are known for their rounded, tailless rumps and tufted ears. 
Inheritance studies have shown that the rumpless (Rp) and ear-tufted (Et) loci each act in 
an autosomal dominant fashion, segregate independently, and are associated with an 
increased rate of embryonic mortality. To find genomic regions associated with Rp and 
Et, we generated genome-wide SNP profiles for a diverse population of 60 Araucana 
chickens using the 60K chicken SNP BeadChip. Genome-wide association studies using 
40 rumpless and 11 tailed birds showed a strong association with rumpless on Gga 2 (Praw 
= 2.45 x 10-10, Pgenome = 0.00575), and analysis of genotypes revealed a 2.14 Mb 
haplotype shared by all rumpless birds. Within this haplotype, a 0.74 Mb critical interval 
containing two Iroquois homeobox genes, Irx1 and Irx2, was unique to rumpless 
Araucana chickens. Irx1 and Irx2 are central for developmental prepatterning, but neither 
gene is known to have a role in mechanisms leading to caudal development. A second 
genome-wide association analysis using 30 ear-tufted and 28 non-tufted birds revealed an 
association with tufted on Gga 15 (Praw = 6.61 x 10-7, Pgenome = 0.0981). We identified a 
0.58 Mb haplotype common to tufted birds and harboring 7 genes. Because 
homozygosity for Et is nearly 100% lethal, we employed a heterozygosity mapping 
approach to prioritize candidate gene selection. A 60 kb region heterozygous in all 
Araucana chickens contains the complete coding sequence for TBX1 and partial sequence 
for GNB1L. TBX1 is an important transcriptional regulator of embryonic development 
and a key genetic determinant of human DiGeorge syndrome. Herein, we describe 
localization of Rp and Et and identification of positional candidate genes.  
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INTRODUCTION 
There are hundreds of domestic chicken breeds worldwide (1). Breeds were 
generally developed for meat and egg production, but morphological traits, plumage 
color, and other distinctive characteristics were also selected. The Araucana chicken, 
originally from Chile, is a multi-purpose breed initially established for its blue-shelled 
eggs (1,2). Araucana chickens are also known for two other distinguishing traits: a 
rounded, tailless rump and protruding ear-tufts. Although these traits segregate in the 
population, the United States Araucana breed standard requires show birds to possess 
both phenotypes.  
 
The rumpless phenotype is characterized by the absence of all free caudal 
vertebrae and the uropygial gland (3). Without underlying skeletal support, birds with 
caudal truncation lack a fleshy rump and tail feathers (3). An intermediate rumpless 
phenotype, wherein some caudal vertebrae are present but irregularly fused together, is 
thought to result from a modifier gene introduced through crosses with non-Araucana 
tailed chickens (3,4). The rumpless phenotype arises from a defect in caudal patterning 
that is controlled by a dominant gene (Rp) (3). Rumpless Araucana chickens may be 
heterozygous or homozygous for this locus. In test matings, all rumpless intermediates 
were determined to be heterozygous (Rp/rp+) (3). Homozygosity is underrepresented 
among chicks from rumpless to rumpless matings, indicating that the Rp/Rp genotype has 
reduced viability (3,5). Birds having at least one copy of Rp have increased mortality in 
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the embryo stage, with death occurring at 17 to 21 days of incubation (3). Rumpless birds 
also have reduced fecundity as adults (3). 
 
Ear-tufts are feather-covered, epidermal protrusions originating near the ear canal 
(Fig. 1). The mass of tissue forming the protrusion, or peduncle, is believed to develop as 
a result of the incomplete fusion of the hyomandibular arches, and it can vary in position 
and length (from two mm to two cm) (6,7). Tufted chickens may also have structural 
rearrangement of the ears (6). Abnormalities include irregularly shaped external ear 
openings and shortened or absent external auditory canals (6).   
 
Fig. 1. Araucana chicken. (a) General appearance of a rumpless, tufted Araucana chicken. (b) For 




Inheritance studies indicate that tufted is governed by a dominant locus, Et (6,8). 
Test matings show that all tufted birds are heterozygous (Et/et+) and that homozygosity 
for Et is lethal at about 17-19 days of incubation (6,8). Lethality among a portion of 
heterozygous birds is also reported, appearing to occur at 20-21 days of incubation (8). 
Post-hatch mortality is significantly higher among tufted chickens (6,8). 
 
Because tufts can occur unilaterally or bilaterally and may differ in size from one 
side to the other, Et is proposed to have variable expressivity (6). In addition, a paucity of 
tufted progeny from mating studies in 1978 suggests reduced penetrance of the tufted 
locus (6). In 1981, Somes and Pabilonia identified a tufted male that produced excessive 
tufted progeny when crossed with an et+/et+ White Leghorn (86%), and they speculated 
that Et/Et birds may occasionally reach maturity (8). The non-tufted chicks from the Et/Et 
male produced tufted progeny when crossed with an et+/et+ White Leghorn, indicating 
that their predicted genotype does not match their phenotype, providing further evidence 
for variable penetrance.  
 
The aim of our investigation was to localize the genetic bases for the rumpless 
and tufted phenotypes of the Araucana chicken. To this end, we generated genome-wide 
SNP profiles for 60 Araucana chickens using the 60K chicken SNP BeadChip (9). Using 
a genome-wide association approach, we elucidate the chromosomal regions harboring 




Case/control analyses were carried out using 40 rumpless and 11 tailed Araucana 




Fig. 2. Genome-wide association for Rp and Et. After 100,000 permutations, the genome-wide adjusted 
P values (2log10 Pgenome) for each SNP are plotted by chromosome (left). The raw P values for the most 
strongly associated chromosomes are plotted against chromosomal position (right). (a,b) 40 rumpless 
versus 11 tailed Araucana chickens (c,d) 30 tufted versus 28 non-tufted Araucana chickens. 
doi:10.1371/journal.pone.0040974.g002 
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excluded from the rumpless association analysis because of uncertainty concerning their 
phenotype. A total of 191 SNPs were associated with the rumpless phenotype (Praw ≤ 
0.0001), 72 of which were located on Gga 2 (Fig. 2b). The most significant result 
obtained was for SNP Gga_rs13637596, located on chromosome 2 at position 88.95 Mb 
(Praw = 2.45 x 10-10, Pgenome = 0.00575). The next two most significant results were for 
proximal SNPs located at 89.17 Mb (Praw = 1.20 x 10-9, Pgenome = 0.0119) and 89.19 Mb 
(Praw = 1.20 x 10-9, Pgenome = 0.0119).  
 
Analysis of genotypes in the Gga 2 region revealed a 2.14 Mb haplotype (87.99 – 
90.13 Mb) predicted to contain five genes (Fig. 3). All 40 rumpless birds had at least one 
copy of the haplotype: 18 were homozygous and 22 were heterozygous. Partial tailed 
birds were heterozygous. The haplotype was absent in its entirety from the 11 tailed 
birds. Three tailed birds were heterozygous for partial blocks of the haplotype and further 
delimit the critical interval to 0.74 Mb (88.77 - 89.51 Mb). This region contains two 









Analyses for association with the tufted phenotype, using 30 cases and 28 
controls, resulted in 31 significant SNPs, 11 of which map to Gga 15 (Fig. 2c). The most 
significant results were for SNPs Gga_rs10730189 (Praw = 6.61 x 10-7, Pgenome = 0.0981) 
and Gga_rs15762547 (Praw = 9.19 x 10-7, Pgenome = 0.118), located at positions 1.33 Mb 
and 1.30 Mb on chromosome 15, respectively. Four other proximal SNPs also reached 
significance (Fig. 2d).  
 
Analysis of genotypes reveals that 29 of 30 tufted birds shared a haplotype 
extending from the telomere of Gga 15 to position 1.75 Mb. These birds were 
heterozygous for the complete haplotype. Two of 28 non-tufted birds were also 
heterozygous for the haplotype in its entirety. A single tufted bird shared only part of the 
1.75 Mb haplotype, defining a 0.58 Mb (0.90 – 1.48 Mb) critical interval that is 
Fig. 3. Localization of Rp. Physical map showing the relative positions of mapped genes and 
informative SNP markers within the 2.14 Mb rumpless haplotype on Gga 2. Light blue shading denotes 
the rumpless haplotype (alleles are shown in the top row). Dashed lines flank the critical interval 
wherein no tailed birds share the rumpless haplotype.  
doi:10.1371/journal.pone.0040974.g003 
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heterozygous in all 30 tufted birds and contains 7 genes. Because tufted is nearly always 
recessive lethal, blocks of homozygosity for the tufted haplotype were identified to 
reduce the number of candidate genes. Homozygosity blocks in three birds flank a 60 kb 




Fig. 4. Localization of Et. Physical map showing the relative positions of genes and informative SNP 
markers in the associated region of Gga 15. Alleles of the tufted haplotype and positions are shown. 
Pale green bars denote heterozygosity for the tufted haplotype. Black bars denote homozygosity for the 





In this study, we used genome-wide SNP profiles to localize genes causative for 
two breed-defining phenotypes of Araucana chickens, rumpless and ear-tufts. We took 
advantage of the fact that both traits segregate independently in the population by using a 
single data set to carry out an association analysis for each trait. Haplotype analyses 
based on inheritance patterns were used to identify positional candidate genes for both 
traits.   
 
We identified a rumpless haplotype spanning 2.14 Mb and five genes on 
chromosome 2. The haplotype is present in the heterozygous or homozygous state in 
rumpless birds. All 7 birds with partial tails are heterozygous for the rumpless haplotype 
and likely represent the intermediate phenotype described by Dunn and Landauer (3). 
Because rumpless is dominant and fully penetrant, we further delimited the critical 
interval by identifying regions of the haplotype shared by tailed birds. A 0.74 Mb region 
common to all rumpless birds, and absent from 11 tailed birds, harbors Rp.  
 
These data reveal that Rp maps to a region of Gga 2 that is distinct from the 
predicted location of genes previously associated with caudal truncation (10-14). The 
0.74 Mb critical interval contains the Iroquois homeobox genes, Irx1 and Irx2. The 
Iroquois genes encode transcription factors that function in patterning and regionalization 
of tissues early in development (15). Irx1 and Irx2 are prepattern and proneural genes 
first identified in Drosophila and Xenopus (16,17). Studies of gene function suggest that 
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Irx genes have redundant yet distinct roles in development (18,19). Irx genes have been 
knocked out in mice and zebrafish with little effect on tail development (19-23). 
However, the rumpless phenotype is dominant, suggesting that misexpression of Irx1 or 
Irx2 may underlie the trait, rather than loss of function. 
 
We identified SNPs on Gga 15 that are strongly associated with the tufted 
phenotype and define a 0.58 Mb haplotype for which all tufted birds in our cohort are 
heterozygous. No birds are homozygous for the complete tufted haplotype. These data 
support conclusions from previous inheritance studies that suggest nearly 100% of tufted 
birds are heterozygous, and that Et/Et is lethal (6,8).  
 
Two non-tufted Araucana chickens are heterozygous for the tufted haplotype. 
These birds may signify reduced penetrance. Penetrance of the tufted allele is estimated 
to range from 86% to 96% (6,8). Based on the assigned phenotypes and the associated 
haplotype, we observed 94% penetrance in our cohort. Alternatively, these birds may 
have been incorrectly phenotyped by their breeders due to short peduncles or missing 
protruding feathers.  
 
The 0.58 Mb haplotype harbors 7 protein-coding genes. Unlike rumpless, 
identification of the tufted haplotype in non-tufted birds could not be used to narrow the 
critical interval because of reduced penetrance. However, because homozygosity for Et is 
nearly always lethal, we were able to prioritize candidate gene selection using 
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heterozygosity mapping. Tufted birds with blocks of homozygosity extending into the 
0.58 Mb common haplotype were identified, and these regions were deemed less likely to 
harbor the Et locus. These data indicate that Et is located in a region containing partial 
coding sequence for GNB1L, which encodes a protein implicated in neuropsychiatric 
disorders (24,25), and complete coding sequence for TBX1 (26), an important 
transcriptional regulator of embryonic development. 
 
Haploinsufficiency for TBX1 is considered to be the key genetic determinant of 
human DiGeorge syndrome (DGS), which is caused by a heterozygous chromosomal 
deletion of 22q11.2 (27). While the clinical phenotype is highly variable, DGS is 
characterized by craniofacial and cardiovascular abnormalities. Malformations in DGS 
are attributed to disturbed segmentation and patterning of the pharyngeal structures (28). 
Auricular defects common in DGS include narrow or absent external ear canal and 
protruding ears (29). Homozygosity for null mutations of TBX1 in mice and zebrafish 
causes a range of phenotypic effects similar to DGS, including abnormal ear development 
(30,31). Based on phenotypic similarities between the malformations causing ear tufts 
and DGS, TBX1 is a highly plausible candidate gene and the primary focus of ongoing 
work to identify the genetic basis for ear-tufts in Araucana chickens. 
 
In conclusion, we used genome-wide association and haplotype analyses to 
localize Rp and Et to chicken chromosomes 2 and 15, respectively. In addition, we 
identified candidate genes that are immediate targets for future work.  
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MATERIALS AND METHODS 
Ethics Statement 
This study was approved by the Clemson University IACUC protocol number 
2011-041 and IBC protocol number 2010-041. 
 
Study Cohort 
Whole blood for DNA was collected from 6 different flocks of Araucana chickens 
from the United States. Phenotypic information and photographs, when available, were 
provided by owners. Birds with tufts of any size and on either side of the head were 
classified as tufted. Because both traits segregate in the Araucana population, birds were 
selected to ensure that the phenotypes were balanced. Our study cohort comprised 60 
Araucana chickens: 21 rumpless/tufted birds, 20 rumpless/non-tufted birds, 7 tailed/non-
tufted birds, five tailed/tufted birds, five partial/tufted birds, and two partial/non-tufted 
birds. Genomic DNA was isolated using the DNeasy blood and tissue kit (QIAGEN, 
Valencia, USA) and adjusted to a concentration of 50 ng/µL. 
 
Genome-wide Association Mapping 
SNP genotypes were generated using the Illumina 60K chicken SNP BeadChip, 
which has 57,636 SNPs across chromosomes 1 through 28, Z, W, and two unmapped 
linkage groups (9). BeadChips were processed by DNA Landmarks (Quebec, Canada), 
according to manufacturer’s protocols. Raw data files were analyzed using 
GenomeStudio’s Genotyping Module to generate SNP calls. The PLINK Input Report 
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Plug-in v2.1.1 was used to format the data. For analysis, Gga 27, Gga 28, Gga Z, Gga W, 
and microchromosomes were all identified as chromosome zero. Case/control analyses 
using 56,685 SNPs were performed using PLINK (32). Two birds with excessive missing 
data were excluded from all analyses. By convention, Praw values ≤ 0.0001 were 
considered significant. Permutation testing, using 100,000 iterations, was carried out 
using PLINK.  
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Canine familial dermatomyositis (DM) is a spontaneous inflammatory myopathy 
that predominantly affects the collie and Shetland sheepdog breeds. DM is characterized 
by painful lesions on the face and extremities; and, is similar clinically, histologically, 
and immunologically to human juvenile dermatomyositis (human DM). The population 
structure of dogs makes them an excellent model for the study of complex hereditary 
diseases and DM in collie and Shetland sheepdogs is the only animal model described to 
date. To find genomic regions associated with DM, we generated genome-wide SNP 
profiles for a diverse population of 47 collies using the Illumina Canine HD BeadChip. 
Genome-wide association studies using 17 DM-affected and 14 healthy control collies 
showed a single, strong association with DM on CFA 10 (Praw = 1.97x10-6), and analysis 
of genotypes revealed a 10.5 Mb haplotype shared by all DM-affected collies. Currently, 
there are only five mapped genes in this region of the canine reference genome; however, 
based on conservation of synteny with human chromosome 12, this region could contain 
as many as 130 genes. Herein, we describe the localization of DM and discuss positional 





Juvenile dermatomyositis (human DM) is the most common childhood 
inflammatory myopathy, comprising about 85% of all diagnosed cases of inflammatory 
myopathy (1,2). Human DM, which affects 3.2 children per million between the ages of 2 
and 17 in the United States (with similar numbers in the United Kingdom), is a 
vasculopathy that causes a characteristic skin rash and debilitating muscle weakness (3-
5). The current method of diagnosis is based on a criterion and classification system that 
was proposed in 1975 (6,7). In diagnosing human DM, the Bohan and Peter system 
considers five major criteria, which are muscle involvement in the trunk with or without 
respiratory involvement, signs of severe inflammation in muscle biopsy, elevated levels 
of muscle enzymes in the blood, myopathy diagnosed via electrocardiogram, and 
characteristic dermatologic involvement. Definitive diagnosis requires the presence of 
three criteria in addition to dermatologic signs; probable diagnosis requires two criteria in 
addition to dermatologic signs, while possible diagnosis requires one criterion in addition 
to dermatologic signs (6,7). Early diagnosis and proper treatment of the disease are 
important for improving the prognosis for an affected child (8). Calcinosis, abnormal 
calcium deposits in various tissues, has been seen in patients with a long history of 
undiagnosed disease, inadequate therapy, or chronic disease (9,10). Unfortunately, even 
with well-defined criteria, a diagnosis of human DM can be hindered by the variety of 
symptoms of a patient’s initial presentation (8). Once diagnosed, treatment with 
corticosteroids and/or immunosuppressive drugs is necessary for remission or to prevent 
further deterioration (8,9,11-13). The prognosis for a child with human DM is positively 
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correlated with a quick diagnosis and proper treatment (9). The impact of human DM on 
the life of a patient varies, but many children continue to have chronic flare-ups and/or 
suffer from the chronic rashes, lesions, and muscle weakness (8). The etiology of DM is 
not known, but DM is thought to be an autoimmune disease brought on by infection with 
a virus or other agent (14-17). In one study, 71% of human DM patients had a clinical 
history consistent with an infection prior to initial signs of human DM (18). There may be 
a gene or multiple genes that predispose a patient to the condition (19). 
 
 Canine familial dermatomyositis (DM) is a naturally occurring autoimmune 
disease of domestic dogs that is similar in clinical presentation to human DM. DM is 
characterized by an inflammatory response in the skin and muscle tissue, typically around 
the face, paws, and tail. The disease phenotype is highly variable, with signs ranging 
from a mild, transient presentation to a near fatal presentation. Clinical findings 
consistent with DM include the development of skin lesions such as hair loss, redness, 
scaling and crusting on the face, ears, legs, and tail tip. Dogs afflicted with DM often 
develop disfiguring scars and secondary skin infections. In severe cases, inflammation 
affects muscle tissue and can cause muscle atrophy, megaesophagus, aspiration 
pneumonia, and difficulty eating or walking. Muscle involvement can cause a poor 
quality of life and owners often elect for euthanasia. Unfortunately, there is no cure for 
DM and clinical signs may reoccur. Onset of DM ranges from two months to several 
years of age. A dog may have produced multiple litters before the onset of clinical signs, 
making it difficult for breeders to control disease transmission. Current treatment for DM 
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includes the management of clinical signs, such as severe pain and secondary skin 
infections. A twice-daily dose of the drug Pentoxifylline, which increases blood 
circulation, is also recommended (20).  
 
The diagnosis of DM is made by a veterinary histopathologist using skin punch 
biopsies of actively afflicted tissue. All three layers of skin (dermis, epidermis, and 
subcutis) are evaluated for signs of inflammation (Dr. J. Mansell, personal 
communication). Some characteristic signs of DM include vacuolar alteration and 
dilation of the basal cell layer in the epidermis, signs of apoptosis, and sparse superficial 
perivascular lymphocytic infiltrates. When these and other cell changes are observed, 
then a diagnosis of DM is made (Dr. J. Mansell, personal communication). 
 
Two breeds with the highest prevalence of DM are collies and Shetland 
sheepdogs (Shelties). DM has been diagnosed and characterized in both breeds since 
1983 (21-23). These two herding breeds share a recent common ancestor (24) and likely 
share the same original mutation contributing to DM. The exact prevalence of DM is 
unknown, but affected dogs have been found in different breeding lines across the United 
States. Data from two studies suggest that the inheritance pattern of DM is autosomal 
dominant (21, Sherry Lindsey, personal communication). Hargis and colleagues, (21) 
outcrossed an affected male purebred collie and an unaffected female purebred Labrador 
retriever. Three of the four offspring developed clinical signs of DM that were milder 
than those seen in offspring from an inbred litter. The inbred litter was a cross of the 
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aforementioned collie sire and an affected female purebred collie. In an unpublished 
study, two DM-affected purebred Shelties were bred and produced a single puppy that 
never developed clinical signs of DM (Sherry Lindsey, personal communication).  
 
Genome-wide association studies (GWAS) have been successfully used to 
identify simple and complex traits of the dog (25,26). The goal of this work is to identify 
a genetic region(s) of association with DM, utilizing GWAS.  
 
MATERIALS AND METHODS 
Sample Collection 
Local and national collie breeders and collie rescues were contacted by electronic 
methods to solicit research subjects. Whole blood or buccal cells were collected from 
participants by their regular veterinarians. DM-affected collies were required to have a 
histopathology report from a skin punch biopsy with a positive or differential diagnosis 
of DM. Pedigrees from DM affected collies were collected when available. Control 
collies were required to be at least seven years of age or older because, while variable, the 
onset of DM usually occurs prior to 6 years of age. Participants had to be pedigreed, 
without history of a dermatologic condition, and unrelated to any DM affected or control 




Genome-wide Association Mapping 
Genomic DNA was isolated using the DNeasy blood and tissue kit (QIAGEN, 
Valencia, USA) and adjusted to a concentration of 100 ng/µL. Illumina CanineHD 
Infinium BeadChips were used to profile 173,662 SNP genotypes per collie, across 
autosomal chromosomes 1 through 38 and sex chromosomes 39/X and 40/Y. BeadChips 
were processed at the Cornell University Life Sciences Core Laboratories Center (Ithaca, 
New York, USA) according to manufacturer’s protocols. Raw data files were analyzed 
using GenomeStudio’s Genotyping Module to generate SNP calls. The PLINK Input 
Report Plug-in v2.1.1 was used to format the data. Case/control analyses were conducted 
with PLINK (27). By convention, Praw values ≤ 0.0001 were considered significant. R 
(28) was used to generate Manhattan plots from the –log10 of the Praw value for each SNP. 
Permutation testing, using 100,000 iterations, was carried out using PLINK. BeadChip 
SNP positions were remapped to canFam3.  
 
RESULTS 
 Our study cohort consisted of 27 DM-affected (ten females/17 males) and 20 (12 
females/eight males) healthy collies. The age of DM-affected collies ranged from three 
months to 11 years (at the time of sampling), while control dogs were seven to 12 years 
of age. All blood and buccal samples were obtained from the United States, except for a 
single DM-affected collie residing in Australia (no American ancestors in X # 
generations). There was no significant difference in the distribution of males and females 
in this study (p= 0.1476). We were unable to obtain information regarding the severity of 
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the clinical signs of DM in all cases. 
 
  A principal components analysis using all 173,662 SNPs identified five collies that 
did not cluster with the majority of the population, indicating a level of population 
stratification from the remaining collies (Fig. 1). These five were considered outliers, one 
control and four DM-affected collies, and were excluded from further analyses. The 
remaining 42 dogs showed no evidence for population stratification.  
 
 To demonstrate the utility of the assembled cohort, a positive control was mapped 
using GWAS. Hair length in dogs is determined by mutations in FGF5 on chromosome 
32 (29). Smooth in collies refers to a short hair length, which is dominant to rough (long) 
hair. Case/control analyses for eight smooth (six DM-affected/two controls) vs 33 rough 
(15 DM-affected/18 controls) collies were carried out (Fig. 2). The most significantly 
associated SNP was BICF2G630600757 on chromosome 32 (Praw = 4.70 x 10-12), and it 

















Fig. 1. Principal component analysis of the collie cohort shows 42 dogs clustering together and five 
outliers. The x-axis is principal component 1 and the y-axis is principal component 2.  
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Two DM-affected collies for which the diagnosis was questionable were excluded 
from the DM analyses. Case/control analyses were carried out using 21 DM-affected and 
19 healthy collies (Fig. 3A). A total of 88 SNPs were significantly associated with DM 
(Praw ≤0.0001), 71 of which were located at the centromeric end of chromosome 10 (Fig. 
4). The most significant results obtained were for five SNPs between 2.1 Mb and 2.9 Mb 
on chromosome 10 (Praw = 2.23 x 10-7). Permutation testing using 100,000 iterations was 
carried out to reduce any false positive results and the SNPs on chromosome 10 remained 
most significant (Pgenome = 0.01373). Analysis of genotypes in the chromosome 10 
region revealed a 10.5 Mb haplotype for which all DM-affected collies had at least one 
copy (12 homozygous, nine heterozygous). The haplotype was also present in 74% of 
Fig. 2. Manhattan plot showing the results for GWAS for smooth using 173,662 SNPs. The genome-
wide P values (-log10 p) for each SNP are plotted against position on each chromosome. Eight smooth 
collies versus 33 rough collies show a strong association on chromosome 32. The significance threshold 
for this plot is -log10 (p) = 4. 
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healthy collies (two homozygous, 12 heterozygous). There are more than 100 genes in 





Fig 3. Manhattan plots showing the results for GWAS for DM using 173,662 SNPs. The genome-wide 
P values (-log10 p) for each SNP are plotted against position on each chromosome. A. Twenty-one DM-
affected collies versus 19 healthy collies show a strong association on chromosome 10. B. After 
balancing phenotypes, 17 DM-affected collies versus 14 healthy collies still show a strong association 





 Of the genes located in this associated DM haplotype, one has a known visible 
phenotype, SILV. This gene is causative for merle coat patterning, a phenotype that 
segregates in our cohort (30). Merle is autosomal dominant, but dogs having shortened 
versions of the mutation do not show the merle phenotype (termed cryptic merles). To 
determine the merle genotype, a direct mutation test was performed for all collies in our 
study cohort. One DM-affected collie and six healthy controls were determined to be 
merle, which is a significant difference in distribution (p=0.04). One merle healthy 
control did not exhibit the phenotype. To identify the SNPs associated with merle, a 
GWAS was performed using seven merle and 35 non-merle collies. A total of 141 SNPs 
Fig. 4. Scatter plot showing SNP positions along chromosome 10. The raw P values for the most 
strongly associated chromosomes are plotted against chromosomal position for 21 DM-affected collies 
versus 19 healthy collies. The significance threshold for this plot is -log10 (p) = 4. 
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were significantly associated with merle (Praw ≤0.0001), 103 of which were located at the 
centromeric end of chromosome 10. Sixty-five SNPs on chromosome 10 were most 
significant with a p-value of 6.45x10-10. This region is located 2.8 Mb downstream from 
SILV. The five most significant SNPs for DM were not significantly associated with 
merle (Praw=0.003123).  
 
To confirm that our DM results are not an artifact of association with the non-
merle allele in our DM-affected population, the two populations were balanced for merle 
and a second GWAS was conducted. Five merle collies were removed from healthy 
control group, leaving one merle dog in each population. Additionally, both populations 
were balanced for the smooth phenotype. Case/control analyses were rerun for 17 DM-
affected (five females/12 males) and 14 controls (eight females/six males) (Fig. 3B). 
Fifty-six of 68 SNPs significantly associated with DM were on chromosome 10. The 
eight SNPs most significantly associated with DM were on chromosome 10 between 2.1 
Mb and 2.5 Mb (Praw=1.97x10-6). These SNPs were within the haplotype previously 
identified for DM. There are no mapped genes within this region. Two DM-affected 
collies were heterozygous for a region defined by the top ten most significant SNPs, 
while all other DM-affected collies were homozygous. Four SNPs on chromosomes 31, 
32, and 39 also reached significance (Praw ≤0.0001). 
 
DISCUSSION 
 In this study, we assembled a cohort of DM-affected and senior, healthy control 
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collies for which we generated whole-genome SNP profiles for the study of DM. With 
these data, we accurately mapped two coat traits that segregate in our cohort: smooth fur 
and the merle coat pattern. Analyses to identify genes contributing to DM revealed a 
primary region of association at the centromeric end of chromosome 10. Associated 
SNPs span a 10.47 Mb region, and a 10.54 Mb haplotype is common to all affected dogs. 
The haplotype is larger because it spans from the top of chromosome 10, where there are 
no SNPs present on the array. The 70 kb region at the top of chromosome 10 can not be 
excluded because the first SNP on chromosome 10 is within the haplotype for DM and 
there are no markers upstream to break the haplotype. 
 
 Breeding studies have shown DM to be inherited in an autosomal dominant fashion 
(21). Data generated herein support the hypothesis of an autosomal dominant mode of 
inheritance because all affected dogs carried either one or two copies of the associated 
haplotype. There were no correlations between sex or age of onset of DM-affected collies 
relative to zygosity in the associated region. The presence of the haplotype among 
healthy controls suggests that the allele may have reduced penetrance. A secondary factor 
such as an environmental trigger or genetic modifier may be necessary for development 
of the disease. In human DM, the phenotype results from a combination of environmental 
and genetic factors (31). Environmental triggers include exposure to toxicodendrons, 
emotional stress (e.g., the birth of a sibling), and UV radiation (32). 
 
 In our study population, we observed an underrepresentation of merles among the 
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affected collies relative to the controls. The associated region on chromosome 10 
encompasses the merle locus, but our data support inheritance of the DM allele on the 
non-merle chromosome and show that different loci are linked with the two traits.  
 
 The number of genes in the DM haplotype region includes five dog RefSeq genes 
and approximately 130 human RefSeq genes (33,34). The human RefSeq genes are from 
human chromosome 12 (34). The identified DM haplotype region shows conservation of 
synteny with human chromosome 12. Several genes have a role in immune function and 
could be considered candidate genes for DM. Among these are IL23A, which has been 
shown to be upregulated in humans with DM (35), and other cytokines including IL22 
and IL26. IFNG is also found in this region and has been studied in conjunction with 
muscle fiber atrophy in DM patients (36). Other genes in this region are involved in the 
formation of muscle fibers, MYL6, and tissue patterning of skin and nerves, GDF11. 
 
 To narrow the critical interval and reduce the number of candidate genes, future 
studies will focus on DM in other breeds, primarily Shetland sheepdogs. Collies and 
Shetland sheepdogs share a common ancestor in the early herding dog of Scotland and 
have been interbred as recently as the 1950s. It is likely that they share the genetic basis 
for DM. An across-breed approach will allow us to take advantage of the differences in 
homogeneity that exists between the breeds (37). Specifically, by comparing the DM 
haplotype region identified in affected collies to the same region in affected Shetland 
sheepdogs will elucidate differences between the two breeds and refine the critical 
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interval. Upon refinement of the critical interval, positional candidate genes will be 
identified and investigated for candidate causal mutations. 
 
 In conclusion, we used genome-wide association and haplotype analysis to localize 
DM in the collie to canine chromosome 10. There are 130 genes in this region and future 
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Domestic dogs have been under artificial selection by humans for hundreds of 
years. Canis lupus familiaris is unmatched in phenotypic diversity, compared to other 
mammals, and is an excellent model for investigating the genetic basis of phenotypic 
diversity, due to their various physiology, morphology, and behavior traits. We 
resequenced the genome of five American collies to 113-fold coverage using Illumina 
HiSeq paired-end sequencing. Trimmed and concordant reads were mapped to the canine 
reference genome (Broad CanFam3.1), generated from a boxer. We identified more than 
9.7 million single nucleotide polymorphisms (SNPs), which showed concordance rates 
>98% with Illumina BeadChip SNP data. The predicted consequence of each SNP was 
determined based on its position relative to mapped genes. We also identified 671,197 
structural variants including deletions, insertions, inversions, tandem duplications, and 
break points shared by all 5 collies, relative to the canine reference genome. Genetic 
regions, with significantly reduced heterogeneity surrounding a gene(s) under strong 
positive selection, were detected on 9 different chromosomes. Candidate genes for two 
phenotypes (Irish spotting and dolichocephaly) fixed in the collie breed were identified. 
Sequence data generated herein provide a resource for the identification of variants 






The dog, Canis lupus familiaris, has been a best friend to mankind since their 
domestication more than 14,000 years ago (1). Through artificial selection, man has 
created more than 400 different pure breeding lines, each arising from a need for certain 
attributes (2). Selected traits include behaviors like herding, guarding, hunting abilities, 
and morphological features like body size, coat texture, and ear carriage. As a result, dogs 
are the most phenotypically diverse species among mammals. Purebred dogs are 
maintained through closed breeding populations. Levels of homogeneity within breeds 
are very high, while levels between breeds is considerably lower (3). Human populations 
have high rates of heterogeneity and thus require large numbers of individuals to map 
hereditary disorders (4,5). For this reason, purebred dog populations offer great models 
for the study of hereditary diseases in humans. 
 
 Because dog breeds exhibit as many as 340 naturally occurring analogous human 
diseases (6), the NIH prioritized the dog genome for whole-genome sequencing. In 2005, 
the first draft of the canine reference sequence was released: a 7.6 X coverage, high-
quality assembly generated for a female boxer (2). The estimated sequence length, 
including gaps, is 2.5 Gb. Roughly 3% of the sequence assembly was highly repetitive 
and could not be mapped (2). The reference genome covers more than 98% of the 
euchromatic regions (2). This consortium also generated a dense SNP map, using 3 
different cohorts, that consists of more than 2.5 million single nucleotide polymorphisms 
(SNPs) (2). First, the consortium identified within the boxer sequence SNPs having a 
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different allele on two or more unique reads (~770,000 SNPs). Second, they compared 
the boxer draft sequence to the previously published 1.5 X standard poodle sequence 
(~1,460,000 SNPs) (7). Third, shotgun sequence data for nine various dog breeds 
(~100,000 reads each, 0.02-fold coverage), four grey wolves and one coyote (~22,000 
reads each, 0.004-fold coverage) was aligned to the boxer (~440,000 SNPs). There have 
been a total of three different versions (builds) of the canine reference genome. The first 
build was assembled using a version of the ARACHNE program (8) and is referred to as 
CanFam1.0; most of the initial quality analyses of the genome were based on this version 
(2). A second build (CanFam2.0) is an updated assembly that was released in 2005 with 
minimal improvements over CanFam1.0 (2). Currently, canine SNP arrays (Affymetrix 
and Illumina brand) are based on the CanFam2.0 build of the reference genome. In 2012, 
a third build was released (Broad CanFam3.1) with improvements including: an N50 (the 
measure of a majority of the contig lengths in an assembly, 9) ~1.5 times longer, ~8,000 
fewer contigs, and an 8-fold reduction of assembled sequence in gaps (10). The size of 
the canine reference genome in Broad CanFam3.1 is 2.4 Gb (2). 
 
 New methods of whole-genome sequencing technologies were introduced in the 
beginning of the 21st century that allowed for massive parallelization. This high-
throughput method, termed next-generation sequencing (NGS), greatly reduced the cost 
and time for generating data. Illumina’s HiSeq technology simultaneously sequences 
millions of shorter read fragments (11). These short reads can be mapped back to a 
reference genome, but are not ideal for generating a de novo assembly sequence because 
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of the high incidence of misassembling regions containing repeats and the high 
redundancy of the short reads (12).  
 
The whole-genome sequencing projects of three dog breeds have been published, 
a 1.5X coverage of the poodle, a 7.6X coverage of the Boxer, and a 45X coverage of the 
Korean Jindo (poodle, boxer, Korean Jindo references). Herein, we resequenced the 
complete genomes of 5 collies and mapped the data to the CanFam3.1 build of the canine 
reference genome. We identified SNPs and structural variants (insertions, deletions, 
tandem duplications, inversions, and breakpoints) present in the collie and not the boxer. 
We also verified concordance of the SNPs identified in the whole-genome resequencing 
by running Illumina Canine HD BeadChip arrays on the same collies. We then classified 
the effect of the genetic variants we identified (13). Furthermore, we identified 9 
chromosomes with regions of reduced heterogeneity and propose two candidate genes for 
selection in the collie. 
 
MATERIALS AND METHODS 
Sample Collection 
 Collie owners were contacted via electronic methods to solicit research 
participants. Pedigrees, information regarding age, sex, coat color, and hair length, and 
medical histories were collected from purebred American collies.  Whole blood for DNA 
was collected by the primary care veterinarian of each dog. In order to maximize data 
gleaned from the genome sequences, pedigrees were used to select the five most 
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genetically diverse American collies. Two dogs shared a common ancestor in the fourth 
generation while no common ancestors were present in the first six generations of the 
others. Among the dogs selected for sequencing were males and females, roughs and 
smooths, and solids and blue merles (Table 1).  
 
Whole-genome sequencing 
Genomic DNA was isolated using the DNeasy blood and tissue kit (QIAGEN, 
Valencia, USA) and adjusted to a concentration of 50 ng/µL in 10mM Tris-CL buffer pH 
8.5, measured by optical density using a NanoDrop 1000 Spectrophotometer (Thermo 
Scientific, Wilmington, USA). One hundred fifty ng of DNA was used for 2x100 bp 
paired-end sequencing, on an Illumina HiSeq 2000 at the University of Missouri DNA 
Core Facility (Columbia, Missouri, USA). Two compressed fastq files were generated per 
lane containing each end of the pair.  
 
Data preparation 
The quality of each set of reads was examined using FastQC v0.10.1 (14). 
Trimming and sorting of all reads was conducted using Trimmomatic v0.30 (15). The 
output of forward and reverse, paired and unpaired reads were re-examined to verify an 
improvement of quality. Some of the metrics used to assess quality include: improvement 
in the per base sequence quality, the per sequence quality scores, the absence of 
overrepresented sequences, and low kmer content (15). 
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 The Broad CanFam3.1 “soft-masked” assembly sequence (2) was downloaded 
from the UCSC Genome Bioinformatics site (13) and formatted for indexing in Bowtie2 
v2.1.0 (16). “Soft-masked” refers to the representation of repeat sequences as capital 
letters and all other sequences as lower case letters. Bowtie2 was used to align all paired 
forward and reverse reads per lane to the Broad CanFam3.1 genome. SAMtools v0.1.18 
(17) was used to convert the Bowtie2 output alignments for sorting and indexing. 
Interactive Genomics Viewer v2.3 was used to visualize the results (18,19). 
 
DATA ANALYSIS 
Coverage, single nucleotide polymorphism and structural variant discovery 
 GenomeCoverageBed (2009), a part of the bedTools suite v 2.16.2 (20), was used 
to generate data in order to calculate the average sequence coverage for each collie. A 
variant call file (VCF) v4.1 combining all five collies was produced using SAMtools (17) 
and BCFtools (17).  
 
The sorted and indexed result files for all five collies were used as input to Pindel 
v0.2.4t (21) and structural variants (deletions, inversions, tandem duplications, short 
insertions, long insertions, and unassigned breakpoints) relative to the reference genome 
were detected. Structural variants present in all five collies were identified.  
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 The Variant Effect Predictor script release 73 by Ensembl (22) was run on our 
complete VCF containing data from all five collies to categorize the location and/or type 
of amino acid or splice site change predicted by each SNP.  
 
Selective sweeps 
 To identify selective sweeps, we implemented the creeping window method 
described by Qanbari et al. (23). We identified all SNPs in our whole-genome sequence, 
outside of “soft-masked” regions, and used a window size no larger than 1 Mb. We 
ignored gaps of greater than 10 kb between SNPs. If a creeping window had 50 or fewer 
SNPs, then it was not considered in our data set. The heterozygosity (Hp) statistic was 
calculated for all creeping windows. All Hp values were averaged and the standard 
deviation was calculated. Each Hp value was Z-transformed, making the average Hp 
value 0 and the standard deviation equal to 1.  
 
Concordance rate between whole-genome sequence and Illumina arrays 
 Genomic DNA from each collie was adjusted to a concentration of 100 ng/µL. 
Illumina CanineHD Infinium BeadChips were used to profile 173,662 SNP genotypes per 
collie, across autosomal chromosomes 1 through 38 and sex chromosomes 39/X and 
40/Y. The BeadChips were processed at the Cornell University Life Sciences Core 
Laboratories Center (Ithaca, New York, USA) according to manufacturer’s protocols. 
Raw data files were analyzed using GenomeStudio’s (2011.1) Genotyping Module v1.9 
to generate SNP calls. The PLINK Input Report Plug-in v2.1.1 was used to format the 
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data. BeadChip SNP positions were remapped to the Broad CanFam3.1 using the UCSC 
Genome Browser’s LiftOver script (24) to determine the concordance rate with the 





In order to identify the most genetically diverse collies for whole-genome 
sequencing, pedigrees were analyzed to determine relationships. Five genetically diverse 
American collies were selected. Two dogs shared a common ancestor in the fourth 
generation with no common ancestors present in the first six generations amongst the 
others. Among the dogs selected for sequencing were males and females, roughs and 



















































1 M Smooth Solid 1 Yes 
2 F Rough Merle 10 No 
3 M Rough Merle 9 No 
4 M Rough Solid < 1 Yes 
5 F Rough Solid 7 Yes 
 





 Genomic DNA from five collies was sequenced using the Illumina HiSeq 2000 
with individual paired-end libraries.  The following fragments were gel size selected: 
Collie 1 – 478 bp, Collie 2 – 530 bp, Collie 3 – 467 bp, Collie 4 – 526 bp and Collie 5 – 
513 bp. The range of the pass filtering rate was from 75% - 93%. The number of reads 
produced ranged from 531 to 997 million, providing roughly 48 to 75 Gb of sequence 
(see Supplementary Table 1).  
 
Sequence Analysis 
 Paired-end reads were trimmed for low quality scores in the leading 3 bp, trailing 
6 bp, and within a sliding window of size 4 bp. Reads were eliminated if their minimum 
length fell below 36 bp. Reads were mapped to the canine reference genome that was 
“soft-masked” for repeats (Broad CanFam3.1/canFam3) using Bowtie2 with sensitive 
parameters. Genome coverage ranged from 16.8 X – 24.9 X, resulting in a combined 113-
fold coverage.  
 
SNP Detection 
 Putative SNPs were determined by comparing the reference sequence to the 
aligned reads of all five collies. More than 9.7 million unique SNPs were identified 
across the genome, including unmapped linkage groups. Genotype data from Illumina 
Canine HD beadchips were used to validate a subset of the identified SNPs. A total of 
167,692 SNPs were placed on the reference genome (11,740 SNPs from the SNP array 
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could not be remapped to Broad CanFam3.1 and were discarded from further analysis). 
Concordance rates ranged from 98% to over 99% between the BeadChip genotypes and 
whole-genome resequencing genotypes (Table 2). While this method does not validate all 
identified SNPs, the SNPs it does validate were identified as highly informative (25). 
 
  SNPs total 
SNPs 
same SNPs different SNPs NA Concordance 
Collie 1 29,755 29,656 99 525 99.67% 
Collie 2 29,757 29,647 110 523 99.63% 
Collie 3 29,688 29,201 487 592 98.36% 
Collie 4 29,762 29,675 87 518 99.71% 
Collie 5 29,746 29,642 104 534 99.65% 
 
Table 2. Comparison of Illumina CanineHD BeadChip genotypes to sequencing SNPs. These results 
indicate a low false positive rate of SNP discovery. NA genotypes result from missing results from either 
method for a given SNP. 
 
 The Variant Effect Predictor, available through Ensembl, was used to assess and 
categorize the location of all SNPs and small variations, compiled in the VCF file, 
relative to mapped genes present on chromosomes 1 – 38 and X. SNPs were 
characterized based on location (intergenic, intronic, upstream, downstream, splice site, 
5’ UTR, or 3’ UTR) or type of change (frameshift, missense, synonymous, stop gained, 






Structural Variants Detection 
 A total of 4,298,455 structural variants were detected using Pindel (21) including: 
deletions, inversions, short insertions, tandem duplications, long insertions, and other 
unassigned break points (Table 4). A total of 675,341 variants were found to exist in all 
five collies across the genome, including unmapped linkage groups. The remaining 3.6 
million structural variants were not common to all five collies. 
Table 3. SNP Functional class membership for collies. SNPs were identified by sequencing of five 
collie genomes and grouped by predicted functional consequences. The percentage of SNPs in each 
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Table 4. Results from Pindel analyses. All deletions, inversions, short insertions, tandem duplications, 
long insertions, and other break points were identified across the reference genome and existing in all 




We identified 671,197 structural variants on chromosomes 1 – 38 and X that were present 
in all five collies. The remaining 4,144 variants were found in the unmapped linkage 
groups. 
 
 There were 355,762 deletions shared by all five collies. Deletions varied in length 
from one to 32,787 bp, with the average being 40 bp and the median deletion being two 
bp. There were 1,756 inversions between one and 32,887 bp long; the average and 
median inversion of 16,897 bp. Tandem duplications varied from 29 to 32,776 bp, with 
an average and median of 22,160 bp. A total of 259,707 short insertions varied from one 
to 77 bp in length and had an average and median of one bp.  
 
Selective Sweep Discovery 
 We identified regions of pooled heterozygosity (Hp), in order to detect signals of 
recent selection. Z-transformation of the Hp values resulted in a mean value of 0 and a 
standard deviation of 1. The negative ZHp distribution was plotted to show putatively 
selected regions greater than 3.4 standard deviations from the mean (Fig. 1). A region 
with significantly reduced heterogeneity, surrounding a gene(s) being selected for, is 
called a selective sweep. Based on our data, we hypothesize the existence of selective 
sweeps on chromosomes 1, 5, 8, 10, 12, 15, 24, 29, and 34. The SNPs used to demarcate 




















































































































































 In this study, we used an Illumina HiSeq 2000 sequencer and paired-end reads to 
obtain mapped genome sequence of the collie. The high coverage sequence data 
generated herein provides a novel resource for future studies in the breed. Previous work 
from our laboratory indicated that SNPs identified from the canine reference sequence 
project were largely uninformative in collies, presenting a challenge for the mapping of 
phenotypes. In addition to SNPs, our data revealed 671,197 structural variants (deletions, 
insertions, inversions, tandem duplications, and break points) present in all 5 collies. 
 
We identified over 9.7 million SNPs relative to the canine reference genome. This 
number is comparable to that reported by a recent dog resequencing project that reported 
more than 4.6 million SNPs detected from a single male dog (28). The high number of 
SNPs observed in the single Korean Jindo dog, compared this study of five collie dogs, 
may be explained by the Korean Jindo breed being more divergent from the boxer or by 
mapping error in the Korean Jindo’s aligned sequence (28).  Further indication that the 
collie exhibits increased homozygosity is provided by a large number of chromosomes 
having possible selective sweeps. A total of 9 chromosomes whose loss of heterozygosity 
would indicate fixation of long stretches of DNA were identified.  
 
Two chromosomes, CFA12 and 15, were of specific interest because they harbor 
dog leukocyte antigen (DLA) genes and KITLG, respectively. The significant reduction 
of heterogeneity surrounding these genes suggests the presence of selective sweeps. DLA 
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is important in immune recognition and regulation (29,30). KITLG encodes the ligand of 
the tyrosine-kinase receptor and harbors mutations in other species that affect 
melanogenesis (31). All collies are fixed for a coat pattern termed Irish spotting, which is 
characterized by a white collar around the neck, white feet, and a white tail tip. Although 
no coding mutations were detected in KITLG, two 200-300 bp deletions in the 5’ region 
are homozygous in all five collies and will be further investigated as candidate mutations 
for Irish spotting. 
 
A selective sweep on CFA 24 encompasses BMP7, a gene important in skeletal 
patterning (32). Bone and cartilage result from the transformation of mesenchymal cells 
with a protein encoded by BMP7. This gene may be involved in the head morphology of 
collies, characterized by distinct dolichocephaly – extremely long muzzles relative to the 
width of their heads. Other chromosomes displayed comparable levels of sweeps and 
analysis of these regions is ongoing.  
 
A large number of structural variants (deletions, insertions, tandem repeats, 
inversions, and unassigned breakpoints) were observed among the collie genomes. The 
length of some variants was extremely long, and further investigation of individual 
variants revealed the presence of false positives. Because the software, Pindel (21), 
analyzing the data had no threshold set regarding a minimum number of reads, if only 
one read in each of the collies matched the variant, then it was called. This shortcoming 
was most notable among the deletion class of variants. Several extremely large deletions 
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were present in all five dogs, but were not supported by a majority of the reads in the 
regions. Without the support of approximately 50% of the total reads per dog, these 
deletions are erroneous. Future work should include additional analyses to increase the 
stringency of read thresholds.   
 
 The very high concordance rates between the whole-genome resequencing data 
and the BeadChips confirm that both data sets are high-quality. By extension, the 
unvalidated SNPs are considered to be of the same quality. Of the whole-genome 
resequencing SNPs that were discarded, 13 were from the Y chromosome, which is not 
covered by the canine reference sequence. The variant predictor software by Ensembl 
identified any functional effect changes resulting from SNPs identified in the collie 
genome. While many SNPs were predicted to result in missense, nonsense, and 
frameshift mutations, these data are based on predicted coding regions and do not account 
for unmapped genes or errors in the annotation. The investigation and validation of these 
variants is beyond the scope of this study. 
 In conclusion, we generated 113X coverage resequencing data of the collie 
genome. Additional data are necessary to determine the significance of the structural 
variants and the selective sweeps identified herein.   
 138 
REFERENCES 
1. Moody JA, Clark LA, Murphy KE (2006) Breed Clubs and Canine History. In The 
Dog and its Genome. Cold Spring Harbor, New York: Cold Spring Harbor 
Laboratory Press pp1-18. 
2. Lindblad-Toh K, Wade CM, Mikkelsen TS, Karlsson EK, Jaffe DB et al. (2005) 
Genome sequence, comparative analysis and haplotype structure of the domestic 
dog Nature Dec 8 438(7069):803-19.  
3. Parker HG, Sutter NB, Ostrander EA (2006) Understanding Genetic Relationships 
among Purebred Dogs: The PhyDo Project. In The Dog and its Genome. Cold Spring 
Harbor, New York: Cold Spring Harbor Laboratory Press pp.141-158. 
4. Kidambi S, Ghosh S, Kotchen JM, Gim CE, Krishnaswami S et al. (2012). Non-
replication study of a genome-wide association study for hypertension and blood 
pressure in African Americans. BMC Medical Genetics. 13:27.  
5. Tanikawa C, Urabe Y, Matsuo K, Kubo M, Takahashi A et al. (2012). Nature 
Genetics. 44(4): 430-4. 
6. The University of Sydney (2013, Nov 15) OMIA – Online Mendelian Inheritance in 
Animals Retrieved November 15, 2013 from http://omia.angis.org.au/home/. 
7. Kirkness EF, Bafna V, Halpern AL, Levy S, Remington K et al. (2003) The dog 
genome: survey sequencing and comparative analysis. Science 301:1898-1903. 
8. Jaffe DB, Butler J, Gnerre S, Mauceli E, Lindblad-Toh K et al. (2003) Whole-genome 
sequence assembly for mammalian genomes: Arachne 2. Genome Research 13: 91–
96. 
 139 
9. National Center for Biotechnology (2008, Jan. 6) Commonly Used Genome Terms 
Retrieved November 15, 2013 from 
http://www.ncbi.nlm.nih.gov/projects/genome/glossary.shtml/. 
10. NCBI (2011, Nov. 2) CanFam3.1 – Assembly. NCBI Retreieved September 4, 2013, 
from http://www.ncbi.nlm.nih.gov/assembly/GCF_000002285.3/. 
11. Illumina (2013) A sequencer for every need. Every Budget. Every lab Retrieved on 
November 15, 2013 from http://www.illumina.com/systems/sequencing.ilmn/. 
12. Illumina (2010) Technical Note: Sequencing. De Novo Assembly Using Illumina 
Reads Retrieved November 15, 2013 from 
http://res.illumina.com/documents/products/technotes/technote_denovo_assembly_ec
oli.pdf/. 
13. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH et al. (2002) The human 
genome browser at UCSC. Genome Res Jun 12 (6):996-1006. 
14. Babragan Bioinformatics (2012, Mar. 5) FastQC A Quality Control Tool for High 
Throughput Sequence Data. FastQC Retrieved September 4, 2013, from 
http://www.bioinformatics.babraham.ac.uk/projects/fastqc/. 
15. Lohse M, Bolger AM, Nagel A, Fernie AR, Lunn JE et al. (2012) A user-friendly, 
integrated software solution for RNA-Seq-based transcriptomics. Nucleic Acids Res 
Jul 40(Web Server issue):W622-7. 
16. Langmead B, Salzberg S (2012) Fast gapped-read alignment with Bowtie 2. Nature 
Methods. 9:357-359. 
 140 
17. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J et al. (2009). The Sequence 
alignment/map (SAM) format and SAMtools. Bioinformatics, 25:2078-9.  
18. Thorvaldsódttir H, Robinson JT, Mesirov JP (2012) Integrative Genomics Viewer 
(IGV): high-performance genomics data visualization and exploration. Briefings in 
Bioinformatics 2012. 
19. Robinson JT, Thirvaldsdóttir H, Winckler W, Guttman M, Lander ES et al. (2011) 
Integrative Genomics Viewer. Nature Biotechnology 29:24-26. 
20. Quinlan AR, Hall IM, (2010) BEDTools: a flexible suite of utilities for comparing 
genomic features. Bioinformatics. 26(6):841–842. 
21. Ye K, Schulz MH, Long Q, Apweiler R, Ning Z (2009) Pindel: a pattern growth 
approach to detect break points of large deletions and medium sized insertions from 
paired-end short reads. Bioinformatics. 25(21): 2865-2871. 
22. McLaren W, Pritchard B, Rios D, Chen Y, Flicek P et al. (2010) Deriving the 
consequences of genomic variants with the Ensembl API and SNP Effect Predictor. 
BMC Bioinformatics 26(16):2069-70. 
23. Qanbari S, Strom TM, Haberer G, Weigend S, Gheyas AA et al. (2012) A High 
Resolution Genome-Wide Scan for Significant Selective Sweeps: An Application to 
Pooled Sequence Data in Laying Chickens. PLoS ONE 10.1371. 
24. Fujita PA, Rhead B, Zweig AS, Hinrichs AS, KarolchikD et al. (2011) The UCSC 
Genome Browser database: update 2011. Nucleic Acids Research. 39:D876-82. 
25. Illumina (2010) Data Sheet: DNA Genotyping. CanineHD BeadChip Retrieved 
November 15, 2013 from 
 141 
http://res.illumina.com/documents/products/datasheets/datasheet_caninehd.pdf/.  
26. Stothard P, Choi JW, Basu U, Sumner-Thomson JM, Meng Y et al. (2011) Whole 
genome resequencing of Black Angus and Holstein cattle for SNP and CNV 
discovery. BMC Genomics. 12:559-572. 
27. Fan WL, Ng CS, Chen CF, Lu MJ, Chen YH et al. (2012) Genome-wide patterns of 
genetic variation in two domestic chickens. Genome Biology and Evolution. 
5(7):1376-1392. 
28. Kim RN, Kim DS, Choi SH, Yoon BH, Kang A et al. (2012) Genome Analysis of the 
Domestic Dog (Korean Jindo) by Massively Parallel Sequencing. DNA Research. 
19(3):275-288. 
29. Tsai KL, Starr-Moss AN, Venkataraman GM, Robinson C, Kennedy LJ et al. (2013) 
Alleles of the major histocompatibility complex play a role in the pathogenesis of 
pancreatic acinar atrophy in dogs Immunogenetics 65:501–509. 
30. Wagner JL, Burnett RC, Storb R (1999) Organization of the canine major 
histocompatibility complex: current perspectives. J Hered 90:35–38. 
31. Huang EJ, Manova K, Packer AI, Sanchez S, Bachvarova RF etal. (1993) The murine 
steel panda mutation affects kit ligand expression and growth of early ovarian 
follicles. Developmental Biology. 157(1):100-109. 
32. Arkell R, Beddington RS (1997) BMP-7 influences pattern and growth of the 










 Next-generation sequencing (NGS) technology has helped with the construction 
of de novo genome sequences and the mapping of other genomes, using reference 
sequences (1-6). In addition, NGS has enhanced the ability to gather the following 
genome-wide sequence information: explaining phenotypes by sequencing genotypes, 
identifying polymorphisms, mapping mutations, and identifying noncoding RNA (7). 
Whole-genome sequencing is a thorough way to investigate a genome; however, single 
nucleotide polymorphisms (SNPs) and BeadChip arrays use information from a 
previously sequenced genome to interrogate a genome more quickly and affordably by 
using genome-wide association studies (GWASs).  
 
GWASs have been used successfully within and across breeds to identify loci and 
mutations underlying diseases, physical characteristics, and behavioral traits of dogs (8–
16). When using this approach, two important factors that must be accounted for are 
population stratification and kinship within the affected and control individuals (17). For 
the work presented here, we collected unrelated dogs and chickens for our GWASs and 
whole-genome resequencing (12,18). In addition, we conducted principal components 
analysis to detect population stratification (15). GWASs have allowed our laboratory to 
study more quickly diseases and other phenotypic traits in the dog.   
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OBJECTIVES 
The goals of the work presented here were as follows: Chapter II - identify the 
genetic mutation that causes the autosomal recessive disease episodic falling syndrome 
(EFS) in the Cavalier King Charles Spaniel. Chapter III - identify loci associated with 
four diseases (pituitary dwarfism, degenerative myelopathy, congenital megaesophagous 
(ME), and pancreatic acinar atrophy (PAA)) in the German shepherd dog. Chapter IV - 
identify the loci associated with the tailless and ear-tuft phenotypes in the Araucana 
chicken. Chapter V - identify loci associated with dermatomyositis (DM) in the collie. 
Chapter VI - generate whole-genome resequencing data for the collie in order to annotate 
single nucleotide polymorphisms (SNPs), insertions, deletions, inversions, tandem 
duplications, break points, and selective sweeps present in the breed relative to the 
reference genome.  
 
EPISODIC FALLING SYNDROME IN CAVALIER KING CHARLES SPANIELS 
 Chapter II reports that a 15.7 kb deletion in the BCAN gene causes EFS in the 
Cavalier King Charles Spaniel (12). Preliminary studies indicated that EFS is inherited in 
an autosomal recessive fashion, suggesting that relatively few individuals could be used 
to identify the associated locus. A GWAS, using Affymetrix Canine V2 SNP arrays data 
from 12 individuals (five affected and seven control) and Sanger sequencing of positional 
candidate genes, allowed for the discovery of this mutation (12). The 12 study dogs came 
from the USA, New Zealand, and the UK. Additional testing of unrelated American 
Cavalier King Charles Spaniels revealed a 12.9% carrier rate, making the mutation more 
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common than expected (12). Finally, the use of the developed direct mutation test will 
allow breeders to identify carriers and prevent litters with affected puppies (12). 
 
MULTIPLE DISEASES IN THE GERMAN SHEPHERD DOG 
 A single data set was interrogated for association with both simple and complex 
diseases in Chapter III. Affymetrix arrays were used to generate SNP profiles for 197 
German shepherd dogs, segregating multiple phenotypes. A GWAS for autosomal 
recessive pituitary dwarfism used 4 affected and 193 normal-sized German shepherd 
dogs. Association was detected with a locus on chromosome 9, which included a strong 
candidate gene, LHX3 (15).  
 
Degenerative myelopathy is inherited in an autosomal recessive pattern with 
incomplete penetrance. Significantly associated SNPs proximal to the causative gene, 
SOD1, were identified along with other unlinked loci, suggesting the presence of 
modifying loci (15). Awano et al. (8) identified a missense mutation in SOD1 in German 
shepherd dogs and other breeds as the causative mutation.  
 
ME was thought to be a simple recessive trait, but despite a large population (19 
affected and 177 control), a predominant association was not detected (15). ME was 
associated with a 4.7 Mb haplotype of SNPs on chromosome 12 present in all affected 
German shepherd dog but also in 46% of the control dogs (15). These results support an 
autosomal recessive pattern with incomplete penetrance.  
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PAA is a complex, autoimmune disorder.  GWAS, using 100 affected and 79 
controls, showed significant associations throughout the genome, suggesting either the 
presence of multiple loci with small effects or that PAA may be a heterogeneous disorder 
(15). 
 
RUMPLESSNESS AND EAR-TUFTS IN ARAUCANA CHICKENS 
In Chapter IV, SNP data generated using an Illumina platform was utilized to identify 
loci associated with two traits of the Araucana chicken. Mapping for the rumpless (Rp) 
and ear-tuft (Et) phenotypes in the Araucana chicken revealed associations on 
chromosome 2 and 15, respectively (18). Rp is associated with a 2.14 Mb haplotype, 
which includes a critical region of 0.74 Mb having two homeobox genes: Irx1 and Irx2 
(18). Et is associated with a 0.58 Mb haplotype in all tufted chickens (18). Because 
previous inheritance studies indicate that the trait is homozygous lethal, a 60 kb region 
for which all tufted chickens are heterozygous was identified and harbors the complete 
coding region of TBX1, a plausible candidate gene (18).  
 
Whole-genome resequencing data for the Araucana chicken was generated to 
investigate the associated regions on chromosomes 2 and 15. Unfortunately, there were 
multiple sequencing gaps within both regions. These regions have high GC content, 
requiring special protocols. Future experiments will need to be carried out in order to fill 
in these gaps and to identify the mutations causing the traits.  
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DERMATOMYOSITIS IN THE COLLIE 
 The genetic basis for DM, an inherited autoimmune disease, was investigated in 
the collie in Chapter V. The pattern of inheritance for DM was previously reported to be 
autosomal dominant (19). GWAS identified a genetic region of association on canine 
chromosome 10, and we identified a 10.5 Mb haplotype present in all affected collies 
(nine heterozygous and 12 homozygous). This region on canine chromosome 10 shares 
conservation of synteny with human chromosome 12, which harbors approximately 130 
genes.  
 
Collies and Shetland sheepdogs share a common ancestor in the early herding dog 
of Scotland and have been interbred as recently as the 1950s. As a result, both likely 
share a founding mutation for DM. Using an across-breed approach allows us to take 
advantage of the differences in homogeneity that exists between the breeds (16). An 
across-breed study using Shetland sheepdogs will be carried out in the future in order to 
refine this 10.5 Mb region, and identify positional candidate gene(s).  
 
MAPPING THE COLLIE GENOME 
 Chapter VI describes the whole-genome resequencing of the genomes of five 
collies. A 113-fold coverage of the collie genome was produced, and over 9.7 million 
SNPs were identified; 671,197 structural variants (deletions, insertions, inversions, 
tandem duplications, and break points) were found in all 5 collies. Additionally, the 
identification of selective sweeps indicates recent losses in heterozygosity on the 
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following chromosomes: 1, 5, 8, 10, 12, 15, 24, 29, and 34. Initial analyses identified 
genes on chromosomes 12 (MHC genes), 15 (KITLG), and 24 (BMP7) that may underlie 
traits fixed in the collie. In addition to validating the existing data, further analyses on 
copy-number variation will be performed. Furthermore, data generated herein will be 
used to identify candidate causal mutations for canine DM. 
 
IMPACT 
 In conclusion, this work provides further validation that whole-genome SNP data 
can be used to identify SNPs and haplotypes associated with phenotypes. NGS 
technologies provide an affordable means by which to identify additional SNPs and 
structural variants specific to a population or an individual. When combined, these tools 
provide a powerful method for the dissection of heritable traits in dog and chicken. 
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Supplementary Fig. 1 Principal component analysis of 98 GSDs with PAA versus 79 healthy control 
GSDs. The x axis is principal component 1 and the y axis is principal component 2. Both populations 
appear to be evenly distributed throughout the cluster and no significant stratification was observed  
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Supplementary Table 1: Uncorrected and corrected P values (PAA) are shown for the 
50 SNPs with significant Praw values (P<0.0001). Corrected P values are from 100,000 
permutations (EMP2 or Pgenome) and the Benjamini-Hochberg test (FDR_BH). 
 
SNP Praw EMP2 FDR_BH 
chr35.4925078 1.59E-11 2.00E-05 6.43E-07 
chr12.58146406 9.28E-11 2.00E-05 1.30E-06 
chr28.32676786 9.59E-11 2.00E-05 1.30E-06 
chr12.23177472 1.48E-10 2.00E-05 1.50E-06 
chr33.30105637 1.85E-10 2.00E-05 1.50E-06 
chr15.40294695 3.03E-10 2.00E-05 2.05E-06 
chr7.82831339 2.43E-09 0.00026 1.40E-05 
chr5.51353689 3.44E-09 0.00035 1.73E-05 
chr3.76398656 3.85E-09 0.00039 1.73E-05 
chr33.25987767 5.02E-09 0.00043 2.03E-05 
chr1.9328042 1.18E-08 0.00083 4.36E-05 
chr24.31358922 1.77E-08 0.00115 5.97E-05 
chr37.12660891 3.69E-08 0.00225 0.0001149 
chr9.10239350 4.07E-08 0.00244 0.0001177 
chr6.39598998 2.80E-07 0.01431 0.0007564 
chr13.30418286 3.16E-07 0.01574 0.0007722 
chr10.13435580 3.24E-07 0.01598 0.0007722 
chr35.19780099 3.67E-07 0.01791 0.0008268 
chr28.13143663 4.73E-07 0.02195 0.001009 
chr4.13107661 7.54E-07 0.03298 0.001527 
chr4.4080795 8.72E-07 0.03707 0.001675 
chr14.54484895 9.10E-07 0.03814 0.001675 
chr23.14905565 9.67E-07 0.04017 0.001703 
chr17.44088133 1.47E-06 0.05733 0.002474 
chr5.68085129 1.94E-06 0.0711 0.003082 
chr2.86073514 1.98E-06 0.07227 0.003082 
chr12.12567352 4.83E-06 0.1536 0.007242 
chr10.68614890 5.75E-06 0.1737 0.008223 
chr3.93468384 5.89E-06 0.1771 0.008223 
chr12.27205596 6.76E-06 0.1981 0.009124 
chr12.3781476 8.88E-06 0.2478 0.01161 
chr7.12305239 1.16E-05 0.2998 0.01469 
chr28.38709005 1.41E-05 0.3461 0.01731 
chr26.20243802 1.49E-05 0.3599 0.01778 
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chr12.4698937 1.73E-05 0.3985 0.01999 
chr9.54243104 1.86E-05 0.4241 0.02098 
chr7.5792722 2.79E-05 0.5349 0.03059 
chr2.18072233 3.26E-05 0.5823 0.03474 
chr3.29459535 3.47E-05 0.6062 0.03574 
chr7.11222056 3.53E-05 0.6125 0.03574 
chr6.33280800 4.06E-05 0.655 0.04011 
chr12.3845215 4.72E-05 0.7004 0.04552 
chr7.12424701 4.92E-05 0.7151 0.046 
chrX.87975142 5.00E-05 0.7203 0.046 
chr6.18214638 5.42E-05 0.7426 0.04881 
chr17.5088861 6.64E-05 0.8006 0.0582 
chr7.12310223 6.75E-05 0.808 0.0582 
chr31.36637612 8.75E-05 0.8689 0.07383 
chr17.52274900 9.12E-05 0.8774 0.07542 
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Illumina PE Collie 1 364,699,442 100 478 33,075 -
Illumina PE Collie 1 371,255,612 100 478 33,606 -
Total Collie 1 735,955,054 100 478 66,681 24.3
Illumina PE Collie 2 487,373,242 100 530 38,941 -
Illumina PE Collie 2 484,341,294 100 530 38,937 -
Total Collie 2 971,714,536 100 530 77,878 25.1
Illumina PE Collie 3 264,861,662 100 467 24,184 -
Illumina PE Collie 3 266,131,024 100 467 24,309 -
Total Collie 3 530,992,686 100 467 48,493 16.8
Illumina PE Collie 4 308,226,036 100 526 28,558 -
Illumina PE Collie 4 308,759,182 100 526 28,613 -
Total Collie 4 616,985,218 100 526 57,171 21.9
Illumina PE Collie 5 500,770,100 100 513 37,595 -
Illumina PE Collie 5 495,968,940 100 513 37,173 -
Total Collie 5 996,739,040 100 513 74,768 24.9
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